Human	O
T	O
cell	O
leukemia	O
virus-I	O
(	O
HTLV-I	O
)	O
Tax	B-protein
-mediated	O
apoptosis	O
in	O
activated	B-cell_type
T	I-cell_type
cells	I-cell_type
requires	O
an	O
enhanced	O
intracellular	O
prooxidant	O
state	O
.	O

We	O
have	O
shown	O
that	O
an	O
estradiol-dependent	O
activation	O
of	O
human	O
T	O
cell	O
leukemia	O
virus-I	O
Tax	B-protein
leads	O
to	O
the	O
inhibition	O
of	O
cell	O
proliferation	O
and	O
to	O
the	O
induction	O
of	O
apoptosis	O
.	O

The	O
present	O
study	O
demonstrates	O
that	O
a	O
hormone-dependent	O
activation	O
of	O
Tax	B-protein
promotes	O
an	O
enhanced	O
prooxidant	O
state	O
in	O
stably	B-cell_line
transfected	I-cell_line
Jurkat	I-cell_line
cells	I-cell_line
as	O
measured	O
by	O
changes	O
in	O
the	O
intracellular	O
levels	O
of	O
glutathione	O
and	O
H2O2	O
;	O
these	O
changes	O
are	O
followed	O
by	O
apoptotic	O
cell	O
death	O
.	O

Additional	O
stimulation	O
of	O
the	O
CD3	B-protein
/TCR	B-protein
pathway	O
enhances	O
the	O
oxidative	O
and	O
apoptotic	O
effects	O
.	O

Both	O
Tax	B-protein
-mediated	O
apoptosis	O
and	O
oxidative	O
stress	O
can	O
be	O
potently	O
suppressed	O
by	O
antioxidants	O
,	O
as	O
is	O
seen	O
with	O
the	O
administration	O
of	O
recombinant	B-protein
thioredoxin	I-protein
(	O
adult	B-protein
T	I-protein
cell	I-protein
leukemia-derived	I-protein
factor	I-protein
)	O
or	O
pyrrolidine	O
dithiocarbamate	O
.	O

Hormone-induced	O
Tax	B-protein
activation	O
induces	O
a	O
long-lasting	O
activation	O
of	O
NF-kappaB	B-protein
,	O
which	O
is	O
a	O
major	O
target	O
of	O
reactive	O
oxygen	O
intermediates	O
.	O

The	O
long-term	O
exposure	O
of	O
Jurkat	B-cell_line
cells	I-cell_line
to	O
hormone	O
eventually	O
results	O
in	O
a	O
selection	O
of	O
cell	B-cell_line
clones	I-cell_line
that	O
have	O
lost	O
Tax	B-protein
activity	O
.	O

A	O
subsequent	O
transfection	O
of	O
these	O
apparently	O
``	B-cell_line
nonresponsive	I-cell_line
''	I-cell_line
clones	I-cell_line
allows	O
the	O
recovery	O
of	O
Tax	B-protein
responses	O
in	O
these	O
cells	O
.	O

Our	O
observations	O
indicate	O
that	O
changes	O
in	O
the	O
intracellular	O
redox	O
status	O
may	O
be	O
a	O
determining	O
factor	O
in	O
Tax	B-protein
-mediated	O
DNA	O
damage	O
,	O
apoptosis	O
,	O
and	O
selection	O
against	O
the	O
long-term	O
expression	O
of	O
Tax	B-protein
function	O
.	O

'	NULL
9	NULL
Analytes	NULL
=	NULL
Comprehensive	NULL
Analysis	NULL
n	NULL
MICFOVUG	NULL
Jim	NULL
Ba	NULL
,	NULL
Bb	NULL
,	NULL
C3a	NULL
,	NULL
C4a	NULL
,	NULL
C4d	NULL
,	NULL
CSa	NULL
,	NULL
at	NULL
SCS5b-9	NULL
,	NULL
Factor	NULL
H	NULL
,	NULL
Factor	NULL
I	NULL
QUIDEL	NULL
MULTIPLE	NULL
<	NULL
‘	NULL
For	NULL
Research	NULL
Use	NULL
Only	NULL
unt	NULL
``	NULL
2	NULL
``	NULL
#	NULL
s	NULL
me	NULL
Journal	NULL
of	NULL
Human	NULL
T	NULL
Cell	NULL
Leukemia	NULL
Virus-I	NULL
(	NULL
HTLV	NULL
-L	NULL
)	NULL
‘	NULL
Aﬁ	NULL
'	NULL
:	NULL
'1mmun010	NULL
gy	NULL
Tax-Mediated	NULL
Apoptosis	NULL
in	NULL
Activated	NULL
T	NULL
Cells	NULL
Requires	NULL
an	NULL
Enhanced	NULL
Intracellular	NULL
Prooxidant	NULL
State	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Marek	NULL
Los	NULL
,	NULL
Khashayarsha	NULL
Khazaie	NULL
,	NULL
Klaus	NULL
Schulze-Osthoff	NULL
,	NULL
Patrick	NULL
A.	NULL
Baeuerle	NULL
,	NULL
Volker	NULL
Schirrmacher	NULL
and	NULL
Katerina	NULL
Chlichlia	NULL
J	NULL
Immunol	NULL
1998	NULL
;	NULL
161:3050-3055	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/161/6/3050	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
37	NULL
articles	NULL
,	NULL
16	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/161/6/3050.full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
Human	NULL
T	NULL
Cell	NULL
Leukemia	NULL
Virus-I	NULL
(	NULL
HTLV-I	NULL
)	NULL
Tax-Mediated	NULL
Apoptosis	NULL
in	NULL
Activated	NULL
T	NULL
Cells	NULL
Requires	NULL
an	NULL
Enhanced	NULL
Intracellular	NULL
Prooxidant	NULL
State	NULL
'	NULL
Marek	NULL
Los	NULL
,	NULL
*	NULL
Khashayarsha	NULL
Khazaie	NULL
,	NULL
'	NULL
Klaus	NULL
Schulze-Osthoff	NULL
,	NULL
*	NULL
Patrick	NULL
A.	NULL
Baeuerle	NULL
,	NULL
*	NULL
Volker	NULL
Schirrmacher	NULL
,	NULL
``	NULL
and	NULL
Katerina	NULL
Chlichlia®	NULL
'	NULL
We	NULL
have	NULL
shown	NULL
that	NULL
an	NULL
estradiol-dependent	NULL
activation	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus-I	NULL
Tax	NULL
leads	NULL
to	NULL
the	NULL
inhibition	NULL
of	NULL
cell	NULL
proliferation	NULL
and	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
.	NULL

The	NULL
present	NULL
study	NULL
demonstrates	NULL
that	NULL
a	NULL
hormone-dependent	NULL
activation	NULL
of	NULL
Tax	NULL
promotes	NULL
an	NULL
enhanced	NULL
prooxidant	NULL
state	NULL
in	NULL
stably	NULL
transfected	NULL
Jurkat	NULL
cells	NULL
as	NULL
measured	NULL
by	NULL
changes	NULL
in	NULL
the	NULL
intracellular	NULL
levels	NULL
of	NULL
glutathione	NULL
and	NULL
H,0	NULL
;	NULL
,	NULL
;	NULL
these	NULL
changes	NULL
are	NULL
followed	NULL
by	NULL
apoptotic	NULL
cell	NULL
death	NULL
.	NULL

Additional	NULL
stimulation	NULL
of	NULL
the	NULL
CD3/TCR	NULL
pathway	NULL
enhances	NULL
the	NULL
oxidative	NULL
and	NULL
apoptotic	NULL
effects	NULL
.	NULL

Both	NULL
Tax-mediated	NULL
apoptosis	NULL
and	NULL
oxidative	NULL
stress	NULL
can	NULL
be	NULL
potently	NULL
suppressed	NULL
by	NULL
antioxidants	NULL
,	NULL
as	NULL
is	NULL
seen	NULL
with	NULL
the	NULL
administration	NULL
of	NULL
recombinant	NULL
thioredoxin	NULL
(	NULL
adult	NULL
T	NULL
cell	NULL
leukemia-derived	NULL
factor	NULL
)	NULL
or	NULL
pyrrolidine	NULL
dithiocarbamate	NULL
.	NULL

Hormone-induced	NULL
Tax	NULL
activation	NULL
induces	NULL
a	NULL
long-lasting	NULL
activation	NULL
of	NULL
NF-B	NULL
,	NULL
which	NULL
is	NULL
a	NULL
major	NULL
target	NULL
of	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
.	NULL

The	NULL
long-term	NULL
exposure	NULL
of	NULL
Jurkat	NULL
cells	NULL
to	NULL
hormone	NULL
eventually	NULL
results	NULL
in	NULL
a	NULL
selection	NULL
of	NULL
cell	NULL
clones	NULL
that	NULL
have	NULL
lost	NULL
Tax	NULL
activity	NULL
.	NULL

A	NULL
subsequent	NULL
transfection	NULL
of	NULL
these	NULL
apparently	NULL
``	NULL
nonresponsive	NULL
``	NULL
clones	NULL
allows	NULL
the	NULL
recovery	NULL
of	NULL
Tax	NULL
responses	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Our	NULL
observations	NULL
indicate	NULL
that	NULL
changes	NULL
in	NULL
the	NULL
intracellular	NULL
redox	NULL
status	NULL
may	NULL
be	NULL
a	NULL
determining	NULL
factor	NULL
in	NULL
Tax-mediated	NULL
DNA	NULL
damage	NULL
,	NULL
apoptosis	NULL
,	NULL
and	NULL
selection	NULL
against	NULL
the	NULL
long-term	NULL
expression	NULL
of	NULL
Tax	NULL
function	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1998	NULL
,	NULL
161	NULL
:	NULL
3050-3055.	NULL
uman	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
(	NULL
HTLV	NULL
)	NULL
is	NULL
the	NULL
only	NULL
human	NULL
retrovirus	NULL
to	NULL
be	NULL
causatively	NULL
associated	NULL
with	NULL
human	NULL
neo-	NULL
plasia	NULL
.	NULL

A	NULL
long-term	NULL
persistence	NULL
of	NULL
HTLV-I	NULL
leads	NULL
to	NULL
the	NULL
malignant	NULL
transformation	NULL
of	NULL
cells	NULL
that	NULL
results	NULL
in	NULL
adult	NULL
T	NULL
cell	NULL
leukemia	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

Extensive	NULL
in	NULL
vitro	NULL
passaging	NULL
of	NULL
infected	NULL
human	NULL
T	NULL
lymphocytes	NULL
eventually	NULL
leads	NULL
to	NULL
the	NULL
appearance	NULL
of	NULL
immortalized	NULL
cells	NULL
with	NULL
an	NULL
activated	NULL
phenotype	NULL
.	NULL

These	NULL
T	NULL
cells	NULL
constitutively	NULL
express	NULL
the	NULL
IL-2Ra	NULL
subunit	NULL
,	NULL
several	NULL
lymphokines	NULL
such	NULL
as	NULL
IL-4	NULL
and	NULL
IL-6	NULL
,	NULL
and	NULL
a	NULL
potent	NULL
radical-scavenging	NULL
and	NULL
reducing	NULL
agent	NULL
known	NULL
as	NULL
adult	NULL
T	NULL
cell	NULL
leukemia-derived	NULL
factor/human	NULL
thioredoxin	NULL
(	NULL
ADF	NULL
)	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

4	NULL
)	NULL
.	NULL

HTLV-I	NULL
carries	NULL
its	NULL
own	NULL
potential	NULL
oncogene	NULL
,	NULL
Tax	NULL
,	NULL
which	NULL
has	NULL
no	NULL
cellular	NULL
counterpart	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
and	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
transforming	NULL
properties	NULL
of	NULL
the	NULL
virus	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Tax	NULL
protein	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
promote	NULL
the	NULL
transcriptional	NULL
transactivation	NULL
of	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
growth-associated	NULL
genes	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
it	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
a	NULL
Tax-induced	NULL
expression	NULL
of	NULL
the	NULL
IL-2Ra	NULL
subunit	NULL
*Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
I	NULL
,	NULL
Eberhard-Karls	NULL
University	NULL
,	NULL
Tiibingen	NULL
,	NULL
Germany	NULL
:	NULL
;	NULL
*Division	NULL
of	NULL
Cellular	NULL
Immunology	NULL
,	NULL
Tumor	NULL
Immunology	NULL
Program	NULL
,	NULL
German	NULL
Cancer	NULL
Research	NULL
Center	NULL
,	NULL
Heidelberg	NULL
,	NULL
Germany	NULL
;	NULL
and	NULL
*Tularik	NULL
Inc.	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
94080	NULL
Received	NULL
for	NULL
publication	NULL
March	NULL
12	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
May	NULL
19	NULL
,	NULL
1998	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
the	NULL
Deutsche	NULL
Forschungsgemeinschaft	NULL
and	NULL
the	NULL
Lady	NULL
Tata	NULL
Foundation	NULL
.	NULL

2	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Katerina	NULL
Chlichlia	NULL
,	NULL
Division	NULL
of	NULL
Cellular	NULL
Immunology	NULL
,	NULL
Tumor	NULL
Immunology	NULL
Program	NULL
,	NULL
German	NULL
Cancer	NULL
Research	NULL
Center	NULL
,	NULL
Im	NULL
Neuenheimer	NULL
Feld	NULL
280	NULL
,	NULL
D-69120	NULL
Heidelberg	NULL
,	NULL
Germany	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
k.chlichlia	NULL
@	NULL
dkfz-heidelberg.de	NULL
3	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
HTLV	NULL
,	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
;	NULL
ER	NULL
,	NULL
estrogen	NULL
receptor	NULL
;	NULL
GSH	NULL
,	NULL
glutathione	NULL
;	NULL
ADF	NULL
,	NULL
adult	NULL
T	NULL
cell	NULL
leukemia-derived	NULL
factor/human	NULL
thiore-doxin	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
PDTC	NULL
,	NULL
pyrrolidine	NULL
dithiocarbamate	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
PI	NULL
,	NULL
propidium	NULL
iodide	NULL
;	NULL
MCB	NULL
,	NULL
monochlo-robimane	NULL
;	NULL
ROL	NULL
,	NULL
reactive	NULL
oxygen	NULL
intermediate	NULL
;	NULL
DCFH	NULL
,	NULL
2',7'-dichlorofluorescein	NULL
diac-ctate	NULL
;	NULL
CD95L	NULL
,	NULL
CD95	NULL
ligand	NULL
;	NULL
LTR	NULL
,	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

Copyright	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
promotes	NULL
autocrine	NULL
stimulation	NULL
and	NULL
consequently	NULL
the	NULL
transformation	NULL
of	NULL
HTLV-L-infected	NULL
T	NULL
cells	NULL
(	NULL
8-11	NULL
)	NULL
.	NULL

Thus	NULL
far	NULL
,	NULL
however	NULL
,	NULL
only	NULL
a	NULL
single	NULL
report	NULL
has	NULL
described	NULL
the	NULL
immortalization	NULL
of	NULL
human	NULL
T	NULL
cells	NULL
through	NULL
the	NULL
expression	NULL
of	NULL
Tax	NULL
alone	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
the	NULL
immortalized	NULL
T	NULL
cells	NULL
were	NULL
particularly	NULL
sensitive	NULL
to	NULL
activation	NULL
via	NULL
the	NULL
CD3/	NULL
TCR	NULL
complex	NULL
;	NULL
this	NULL
complex	NULL
promoted	NULL
their	NULL
mitosis	NULL
under	NULL
conditions	NULL
in	NULL
which	NULL
IL-2R	NULL
function	NULL
was	NULL
presumably	NULL
blocked	NULL
(	NULL
12	NULL
)	NULL
.	NULL

A	NULL
previous	NULL
study	NULL
using	NULL
Jurkat	NULL
T	NULL
cells	NULL
expressing	NULL
a	NULL
conditional	NULL
version	NULL
of	NULL
Tax	NULL
,	NULL
which	NULL
was	NULL
generated	NULL
by	NULL
the	NULL
fusion	NULL
of	NULL
the	NULL
Tax	NULL
protein	NULL
of	NULL
HTLV-I	NULL
and	NULL
the	NULL
hormone-binding	NULL
domain	NULL
of	NULL
the	NULL
human	NULL
estrogen	NULL
receptor	NULL
(	NULL
ER-Tax	NULL
)	NULL
,	NULL
documented	NULL
an	NULL
inhibition	NULL
of	NULL
proliferation	NULL
and	NULL
an	NULL
induction	NULL
of	NULL
apoptotic	NULL
cell	NULL
death	NULL
upon	NULL
the	NULL
hormone-dependent	NULL
activation	NULL
of	NULL
Tax	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
were	NULL
able	NULL
to	NULL
demonstrate	NULL
that	NULL
caspases	NULL
mediate	NULL
Tax-induced	NULL
apoptotic	NULL
T	NULL
cell	NULL
death	NULL
and	NULL
that	NULL
the	NULL
CD95-signaling	NULL
pathway	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
this	NULL
Tax-triggered	NULL
apoptotic	NULL
process	NULL
in	NULL
our	NULL
recent	NULL
work	NULL
using	NULL
this	NULL
hormone-inducible	NULL
system	NULL
(	NULL
14	NULL
)	NULL
.	NULL

The	NULL
antiproliferative	NULL
effects	NULL
were	NULL
dependent	NULL
upon	NULL
the	NULL
duration	NULL
of	NULL
ER-Tax	NULL
activity	NULL
and	NULL
were	NULL
significantly	NULL
enhanced	NULL
when	NULL
the	NULL
CD3/TCR	NULL
complex	NULL
was	NULL
simultaneously	NULL
activated	NULL
(	NULL
13	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
corroborated	NULL
the	NULL
report	NULL
of	NULL
apoptotic	NULL
cell	NULL
death	NULL
in	NULL
Tax-transformed	NULL
Rat-1	NULL
fibroblasts	NULL
after	NULL
serum	NULL
starvation	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
cooperative	NULL
action	NULL
of	NULL
Tax	NULL
and	NULL
CD3	NULL
in	NULL
T	NULL
cells	NULL
supports	NULL
the	NULL
reported	NULL
overlap	NULL
of	NULL
the	NULL
mode	NULL
of	NULL
action	NULL
of	NULL
Tax	NULL
with	NULL
the	NULL
CD28	NULL
T	NULL
cell	NULL
costimulatory	NULL
pathway	NULL
(	NULL
16	NULL
)	NULL
.	NULL

The	NULL
transcriptional	NULL
complex	NULL
that	NULL
is	NULL
activated	NULL
by	NULL
CD28	NULL
is	NULL
closely	NULL
related	NULL
to	NULL
NF-KB	NULL
.	NULL

Both	NULL
play	NULL
crucial	NULL
roles	NULL
in	NULL
the	NULL
TCR-independent	NULL
,	NULL
cyclosporin	NULL
A-insensitive	NULL
pathways	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Both	NULL
are	NULL
known	NULL
to	NULL
respond	NULL
to	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
(	NULL
ROIs	NULL
)	NULL
and	NULL
to	NULL
be	NULL
selectively	NULL
suppressed	NULL
by	NULL
antioxidants	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
potent	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
HTLV-I	NULL
Tax	NULL
is	NULL
,	NULL
at	NULL
least	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
,	NULL
also	NULL
blocked	NULL
by	NULL
antioxidants	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
seems	NULL
likely	NULL
that	NULL
Tax	NULL
may	NULL
induce	NULL
prooxidant	NULL
conditions	NULL
.	NULL

Such	NULL
redox	NULL
changes	NULL
are	NULL
expected	NULL
to	NULL
function	NULL
in	NULL
a	NULL
cooperative	NULL
manner	NULL
,	NULL
with	NULL
redox	NULL
changes	NULL
induced	NULL
through	NULL
Ag	NULL
or	NULL
mAb	NULL
stimulation	NULL
of	NULL
the	NULL
0022-1767/98/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
CD3/TCR	NULL
complex	NULL
and	NULL
leading	NULL
to	NULL
apoptosis	NULL
in	NULL
ER-Tax-expressing	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

To	NULL
test	NULL
the	NULL
above	NULL
possibilities	NULL
,	NULL
we	NULL
have	NULL
generated	NULL
ER-Tax-expressing	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

A	NULL
hormone-dependent	NULL
activation	NULL
of	NULL
Tax	NULL
leads	NULL
to	NULL
the	NULL
frans-activation	NULL
of	NULL
Tax-responsive	NULL
promoters	NULL
in	NULL
an	NULL
inducible	NULL
manner	NULL
.	NULL

We	NULL
report	NULL
that	NULL
a	NULL
hormone-dependent	NULL
posttranslational	NULL
induction	NULL
of	NULL
ER-Tax	NULL
leads	NULL
to	NULL
rapid	NULL
changes	NULL
in	NULL
the	NULL
intracellular	NULL
levels	NULL
of	NULL
H	NULL
,	NULL
O	NULL
,	NULL
and	NULL
glutathione	NULL
(	NULL
GSH	NULL
)	NULL
,	NULL
promoting	NULL
an	NULL
intracellular	NULL
prooxidant	NULL
state	NULL
.	NULL

Concomitant	NULL
activation	NULL
of	NULL
the	NULL
CD3/	NULL
TCR	NULL
pathway	NULL
exaggerates	NULL
the	NULL
oxidative	NULL
stress	NULL
and	NULL
causes	NULL
DNA	NULL
fragmentation	NULL
in	NULL
live	NULL
cells	NULL
.	NULL

Antioxidants	NULL
block	NULL
the	NULL
Tax-mediated	NULL
DNA	NULL
damage	NULL
.	NULL

A	NULL
long-term	NULL
exposure	NULL
of	NULL
the	NULL
cells	NULL
to	NULL
active	NULL
ER-Tax	NULL
selects	NULL
for	NULL
or	NULL
renders	NULL
surviving	NULL
cells	NULL
unresponsive	NULL
to	NULL
Tax	NULL
and	NULL
allows	NULL
an	NULL
apparent	NULL
recovery	NULL
of	NULL
the	NULL
intracellular	NULL
redox	NULL
status	NULL
.	NULL

These	NULL
observations	NULL
indicate	NULL
that	NULL
changes	NULL
in	NULL
the	NULL
intracellular	NULL
redox	NULL
state	NULL
may	NULL
be	NULL
a	NULL
determining	NULL
factor	NULL
in	NULL
Tax-mediated	NULL
DNA	NULL
damage	NULL
,	NULL
apoptosis	NULL
,	NULL
and	NULL
unresponsiveness	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cell	NULL
lines	NULL
and	NULL
transfections	NULL
Jurkat	NULL
T	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
stably	NULL
transfected	NULL
to	NULL
express	NULL
ER-Tax	NULL
or	NULL
ER-ATax	NULL
fusion	NULL
constructs	NULL
were	NULL
maintained	NULL
in	NULL
culture	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
13	NULL
)	NULL
.	NULL

The	NULL
ER-Tax	NULL
construct	NULL
carried	NULL
the	NULL
ligand-binding	NULL
domain	NULL
of	NULL
the	NULL
human	NULL
ER	NULL
at	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
Tax	NULL
;	NULL
the	NULL
ER-ATax	NULL
construct	NULL
encoded	NULL
an	NULL
inactive	NULL
fusion	NULL
protein	NULL
that	NULL
was	NULL
missing	NULL
the	NULL
first	NULL
12	NULL
aa	NULL
of	NULL
Tax	NULL
.	NULL

Transient	NULL
transfections	NULL
and	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
assays	NULL
were	NULL
performed	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
13	NULL
)	NULL
using	NULL
3	NULL
pug	NULL
of	NULL
the	NULL
CAT	NULL
reporter	NULL
plasmids	NULL
p	NULL
(	NULL
HTLV-DLTR-CAT	NULL
or	NULL
p	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
,	NULL
-CAT	NULL
and	NULL
1	NULL
ug	NULL
of	NULL
transactivator	NULL
(	NULL
ER-Tax-expressing	NULL
plasmid	NULL
)	NULL
(	NULL
13	NULL
)	NULL
.	NULL

For	NULL
the	NULL
induction	NULL
of	NULL
Tax	NULL
activity	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
1	NULL
wM	NULL
of	NULL
the	NULL
hormone	NULL
17B-estradiol	NULL
(	NULL
Sigma	NULL
,	NULL
Deisenhofen	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

For	NULL
the	NULL
stimulation	NULL
of	NULL
NF-KB	NULL
activity	NULL
(	NULL
positive	NULL
control	NULL
)	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
20	NULL
ng/ml	NULL
of	NULL
PMA	NULL
(	NULL
Sigma	NULL
)	NULL
and	NULL
1	NULL
ug/ml	NULL
of	NULL
PHA	NULL
(	NULL
Sigma	NULL
)	NULL
for	NULL
1	NULL
h.	NULL
Recombinant	NULL
ADF	NULL
was	NULL
produced	NULL
in	NULL
Escherichia	NULL
coli	NULL
and	NULL
purified	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
Total	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
using	NULL
a	NULL
high-salt	NULL
detergent	NULL
buffer	NULL
(	NULL
Totex	NULL
)	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
21	NULL
)	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
by	NULL
centrif-ugation	NULL
;	NULL
washed	NULL
once	NULL
in	NULL
ice-cold	NULL
PBS	NULL
;	NULL
and	NULL
resuspended	NULL
in	NULL
4	NULL
cell	NULL
volumes	NULL
of	NULL
Totex	NULL
buffer	NULL
containing	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
350	NULL
mM	NULL
NaCl	NULL
,	NULL
20	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
glycerol	NULL
,	NULL
1	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
of	NULL
Nonidet	NULL
P-40	NULL
,	NULL
1	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.5	NULL
mM	NULL
EDTA	NULL
,	NULL
0.1	NULL
mM	NULL
EGTA	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
0.1	NULL
%	NULL
PMSF	NULL
,	NULL
and	NULL
1	NULL
%	NULL
aprotinin	NULL
.	NULL

The	NULL
cell	NULL
lysate	NULL
was	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
20	NULL
min	NULL
and	NULL
then	NULL
centrifuged	NULL
for	NULL
5	NULL
min	NULL
at	NULL
13,000	NULL
X	NULL
g	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
protein	NULL
content	NULL
of	NULL
the	NULL
supernatant	NULL
was	NULL
determined	NULL
,	NULL
and	NULL
equal	NULL
amounts	NULL
of	NULL
protein	NULL
(	NULL
10-15	NULL
ug	NULL
)	NULL
were	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
mixture	NULL
containing	NULL
20	NULL
ug	NULL
of	NULL
BSA	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Boehringer	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
,	NULL
2	NULL
ul	NULL
of	NULL
a	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
100	NULL
mM	NULL
KCI	NULL
,	NULL
0.5	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
%	NULL
of	NULL
Nonidet	NULL
P-40	NULL
,	NULL
2	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
0.1	NULL
%	NULL
PMSF	NULL
)	NULL
,	NULL
4	NULL
ul	NULL
of	NULL
a	NULL
buffer	NULL
(	NULL
20	NULL
%	NULL
Ficoll	NULL
400	NULL
,	NULL
100	NULL
mM	NULL
HEPES	NULL
,	NULL
300	NULL
mM	NULL
KCI	NULL
,	NULL
10	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
0.1	NULL
%	NULL
PMSF	NULL
)	NULL
,	NULL
and	NULL
10,000	NULL
cpm	NULL
(	NULL
Cerenkov	NULL
)	NULL
of	NULL
a	NULL
*°P-labeled	NULL
NF-KB	NULL
oligonucleotide	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
20	NULL
ul	NULL
.	NULL

An	NULL
NF-	NULL
«	NULL
B	NULL
oligonucleotide	NULL
with	NULL
a	NULL
high-affinity	NULL
NF-B-binding	NULL
motif	NULL
(	NULL
Promega	NULL
,	NULL
Heidelberg	NULL
,	NULL
Germany	NULL
)	NULL
was	NULL
labeled	NULL
with	NULL
[	NULL
y-*P	NULL
]	NULL
JATP	NULL
(	NULL
3000	NULL
Ci/	NULL
mmol	NULL
;	NULL
Amersham	NULL
,	NULL
Braunschweig	NULL
,	NULL
Germany	NULL
)	NULL
and	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

The	NULL
reaction	NULL
mixture	NULL
was	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
25	NULL
min	NULL
.	NULL

Native	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
were	NULL
run	NULL
in	NULL
45	NULL
mM	NULL
Tris-borate	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
.	NULL

NF-	NULL
«	NULL
B-binding	NULL
activity	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
beta-imaging	NULL
of	NULL
native	NULL
gels	NULL
.	NULL

Apoptosis	NULL
assay	NULL
The	NULL
induction	NULL
of	NULL
apoptosis	NULL
was	NULL
measured	NULL
using	NULL
a	NULL
modified	NULL
version	NULL
of	NULL
a	NULL
method	NULL
that	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
loaded	NULL
with	NULL
1	NULL
pg/ml	NULL
of	NULL
Hoechst	NULL
33342	NULL
(	NULL
Molecular	NULL
Probes	NULL
,	NULL
Eugene	NULL
,	NULL
OR	NULL
)	NULL
for	NULL
5	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
then	NULL
transferred	NULL
on	NULL
ice	NULL
while	NULL
protected	NULL
from	NULL
light	NULL
before	NULL
measurement	NULL
.	NULL

After	NULL
transferring	NULL
the	NULL
cells	NULL
to	NULL
flow	NULL
cytometer-com-patible	NULL
tubes	NULL
,	NULL
propidium	NULL
iodide	NULL
(	NULL
PT	NULL
)	NULL
was	NULL
added	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
0.5	NULL
ug/ml	NULL
.	NULL

FACS	NULL
Vantage	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Heidelberg	NULL
,	NULL
Germany	NULL
)	NULL
was	NULL
used	NULL
for	NULL
sample	NULL
acquisition	NULL
and	NULL
data	NULL
analysis	NULL
.	NULL

Hoechst	NULL
33342	NULL
was	NULL
excited	NULL
at	NULL
360	NULL
nm	NULL
,	NULL
and	NULL
emission	NULL
was	NULL
measured	NULL
at	NULL
450	NULL
nm	NULL
.	NULL

PI	NULL
was	NULL
excited	NULL
at	NULL
488	NULL
nm	NULL
,	NULL
and	NULL
emission	NULL
was	NULL
detected	NULL
at	NULL
610	NULL
nm	NULL
.	NULL

The	NULL
cell	NULL
population	NULL
that	NULL
was	NULL
bright	NULL
for	NULL
Hoechst	NULL
33342	NULL
staining	NULL
but	NULL
still	NULL
negative	NULL
for	NULL
PI	NULL
was	NULL
considered	NULL
to	NULL
be	NULL
undergoing	NULL
apoptosis	NULL
.	NULL

3051	NULL
Intracellular	NULL
GSH	NULL
measurement	NULL
The	NULL
measurement	NULL
of	NULL
intracellular	NULL
GSH	NULL
was	NULL
performed	NULL
according	NULL
to	NULL
Rice	NULL
et	NULL
al	NULL
.	NULL

(	NULL
23	NULL
)	NULL
with	NULL
modifications	NULL
.	NULL

Cells	NULL
that	NULL
had	NULL
been	NULL
kept	NULL
in	NULL
culture	NULL
medium	NULL
were	NULL
loaded	NULL
with	NULL
20	NULL
uM	NULL
of	NULL
monochlorobimane	NULL
(	NULL
MCB	NULL
)	NULL
(	NULL
Molecular	NULL
Probes	NULL
)	NULL
for	NULL
10	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
stopped	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
ice-	NULL
cold	NULL
PBS	NULL
.	NULL

Cells	NULL
were	NULL
subsequently	NULL
harvested	NULL
,	NULL
washed	NULL
through	NULL
cold	NULL
FCS	NULL
followed	NULL
by	NULL
two	NULL
additional	NULL
washes	NULL
with	NULL
cold	NULL
PBS	NULL
,	NULL
and	NULL
analyzed	NULL
with	NULL
a	NULL
FACS	NULL
Vantage	NULL
flow	NULL
cytometer	NULL
.	NULL

The	NULL
351-	NULL
to	NULL
364-nm	NULL
bandpass	NULL
filter	NULL
was	NULL
used	NULL
for	NULL
excitation	NULL
,	NULL
and	NULL
emission	NULL
was	NULL
detected	NULL
at	NULL
450	NULL
nm	NULL
.	NULL

Dead	NULL
cells	NULL
were	NULL
excluded	NULL
by	NULL
forward/side	NULL
scatter	NULL
gating	NULL
.	NULL

The	NULL
mean	NULL
values	NULL
of	NULL
the	NULL
fluorescence	NULL
signal	NULL
from	NULL
duplicate	NULL
samples	NULL
were	NULL
considered	NULL
for	NULL
data	NULL
analysis	NULL
.	NULL

Fluorescent	NULL
measurement	NULL
of	NULL
intracellular	NULL
peroxides	NULL
with	NULL
2',7	NULL
dichlorofluorescein	NULL
diacetate	NULL
(	NULL
DCFH	NULL
)	NULL
Intracellular	NULL
peroxides	NULL
were	NULL
measured	NULL
according	NULL
to	NULL
Royall	NULL
et	NULL
al	NULL
.	NULL

(	NULL
24	NULL
)	NULL
.	NULL

A	NULL
stock	NULL
solution	NULL
of	NULL
DCFH	NULL
(	NULL
10	NULL
mM	NULL
;	NULL
Molecular	NULL
Probes	NULL
)	NULL
was	NULL
prepared	NULL
under	NULL
nitrogen	NULL
in	NULL
DMSO	NULL
and	NULL
stored	NULL
at	NULL
-20°C	NULL
.	NULL

Cells	NULL
were	NULL
loaded	NULL
with	NULL
5	NULL
uM	NULL
of	NULL
DCFH	NULL
in	NULL
culture	NULL
medium	NULL
at	NULL
37°C	NULL
for	NULL
45	NULL
min	NULL
and	NULL
then	NULL
placed	NULL
on	NULL
ice	NULL
before	NULL
measurement	NULL
.	NULL

Loaded	NULL
cells	NULL
were	NULL
collected	NULL
into	NULL
FACS-compatible	NULL
tubes	NULL
,	NULL
supplemented	NULL
with	NULL
PI	NULL
(	NULL
1	NULL
ug/ml	NULL
!	NULL
)	NULL

(	NULL
Sigma	NULL
)	NULL
,	NULL
and	NULL
measured	NULL
using	NULL
a	NULL
FACScan	NULL
(	NULL
Becton	NULL
Dickinson	NULL
}	NULL
.	NULL

Results	NULL
Stably	NULL
transfected	NULL
ER-Tax	NULL
Jurkat	NULL
cells	NULL
exhibit	NULL
hormone-inducible	NULL
Tax	NULL
activity	NULL
ER-Tax	NULL
fusion	NULL
proteins	NULL
were	NULL
shown	NULL
to	NULL
transactivate	NULL
several	NULL
Tax-responsive	NULL
reporter	NULL
plasmids	NULL
in	NULL
a	NULL
hormone-dependent	NULL
manner	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
generated	NULL
Jurkat	NULL
T	NULL
cells	NULL
stably	NULL
expressing	NULL
inducible	NULL
Tax	NULL
(	NULL
ER-Tax	NULL
)	NULL
or	NULL
an	NULL
inactive	NULL
form	NULL
of	NULL
Tax	NULL
(	NULL
ER-ATax	NULL
)	NULL
.	NULL

The	NULL
transactivation	NULL
potential	NULL
of	NULL
the	NULL
stably	NULL
transfected	NULL
,	NULL
ER-Tax-expressing	NULL
Jurkat	NULL
cells	NULL
was	NULL
determined	NULL
in	NULL
a	NULL
time-course	NULL
experiment	NULL
using	NULL
(	NULL
HTLV-I	NULL
)	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
-	NULL
and	NULL
NF-	NULL
«	NULL
B-dependent	NULL
reporter	NULL
plasmids	NULL
.	NULL

Cells	NULL
were	NULL
preincubated	NULL
for	NULL
different	NULL
lengths	NULL
of	NULL
time	NULL
in	NULL
medium	NULL
with	NULL
or	NULL
without	NULL
estradiol	NULL
and	NULL
then	NULL
transfected	NULL
with	NULL
the	NULL
Tax-responsive	NULL
reporter	NULL
plasmids	NULL
.	NULL

The	NULL
transiently	NULL
transfected	NULL
cells	NULL
were	NULL
cultivated	NULL
for	NULL
another	NULL
2	NULL
days	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
estradiol	NULL
before	NULL
CAT	NULL
reporter	NULL
gene	NULL
assays	NULL
were	NULL
performed	NULL
.	NULL

A	NULL
hormone-dependent	NULL
transactivation	NULL
of	NULL
the	NULL
(	NULL
HTLV-DLTR-	NULL
and	NULL
NF-	NULL
«	NULL
B-controlled	NULL
promoters	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
cells	NULL
that	NULL
were	NULL
cultured	NULL
for	NULL
2	NULL
days	NULL
with	NULL
estradiol	NULL
immediately	NULL
following	NULL
the	NULL
transfections	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
day	NULL
0	NULL
)	NULL
.	NULL

Comparable	NULL
increases	NULL
in	NULL
CAT	NULL
activity	NULL
were	NULL
detected	NULL
with	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
preincubated	NULL
with	NULL
estradiol	NULL
for	NULL
3	NULL
days	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
7	NULL
days	NULL
before	NULL
transfection	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
day	NULL
-7	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
stably	NULL
transfected	NULL
ER-Tax	NULL
Jurkat	NULL
cells	NULL
exhibit	NULL
estradiol-dependent	NULL
Tax-activity	NULL
.	NULL

Long-term	NULL
exposure	NULL
to	NULL
estradiol	NULL
leads	NULL
to	NULL
Tax	NULL
unresponsiveness	NULL
To	NULL
test	NULL
the	NULL
long-term	NULL
effects	NULL
of	NULL
constitutive	NULL
Tax-activity	NULL
,	NULL
cells	NULL
were	NULL
preincubated	NULL
for	NULL
30	NULL
days	NULL
with	NULL
or	NULL
without	NULL
estradiol	NULL
before	NULL
being	NULL
transfected	NULL
with	NULL
the	NULL
Tax-responsive	NULL
plasmids	NULL
.	NULL

Preincubating	NULL
the	NULL
cells	NULL
for	NULL
30	NULL
days	NULL
with	NULL
hormone	NULL
led	NULL
to	NULL
unresponsiveness	NULL
to	NULL
Tax	NULL
,	NULL
which	NULL
reduced	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
(	NULL
HTLV-D	NULL
)	NULL
LTR-	NULL
and	NULL
NF-	NULL
«	NULL
B-driven	NULL
reporter	NULL
gene	NULL
plasmids	NULL
almost	NULL
to	NULL
the	NULL
basal	NULL
level	NULL
of	NULL
unin-duced	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
day	NULL
-30	NULL
)	NULL
.	NULL

Cells	NULL
that	NULL
had	NULL
lost	NULL
responsiveness	NULL
to	NULL
Tax	NULL
due	NULL
to	NULL
1	NULL
mo	NULL
of	NULL
continuous	NULL
culture	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
estradiol	NULL
responded	NULL
to	NULL
a	NULL
new	NULL
transient	NULL
transfection	NULL
of	NULL
exogenous	NULL
ER-Tax	NULL
.	NULL

In	NULL
these	NULL
cells	NULL
,	NULL
a	NULL
hormone-dependent	NULL
transactivation	NULL
of	NULL
LTR-	NULL
and	NULL
NF-	NULL
«	NULL
B-dependent	NULL
reporter	NULL
plasmids	NULL
could	NULL
be	NULL
detected	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
day	NULL
-30	NULL
plus	NULL
ER-Tax	NULL
)	NULL
.	NULL

Exposing	NULL
control	NULL
cells	NULL
expressing	NULL
an	NULL
inactive	NULL
(	NULL
truncated	NULL
)	NULL
form	NULL
of	NULL
Tax	NULL
(	NULL
ER-ATax	NULL
)	NULL
to	NULL
estradiol	NULL
for	NULL
the	NULL
same	NULL
time	NULL
periods	NULL
did	NULL
not	NULL
result	NULL
in	NULL
the	NULL
transactivation	NULL
of	NULL
transiently	NULL
transfected	NULL
NF-	NULL
«	NULL
B-	NULL
or	NULL
LTR-CAT	NULL
constructs	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
DNA-binding	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
examined	NULL
by	NULL
EMSA	NULL
for	NULL
different	NULL
timepoints	NULL
after	NULL
the	NULL
activation	NULL
of	NULL
ER-Tax	NULL
.	NULL

Treating	NULL
ER-Tax-expressing	NULL
Jurkat	NULL
cells	NULL
with	NULL
hormone	NULL
resulted	NULL
in	NULL
a	NULL
time-dependent	NULL
,	NULL
marked	NULL
increase	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B-specific	NULL
DNA-binding	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
3052	NULL
FIGURE	NULL
1	NULL
.	NULL

Determination	NULL
of	NULL
Tax	NULL
activity	NULL
in	NULL
the	NULL
ER-Tax-expressing	NULL
Jurkat	NULL
clone	NULL
after	NULL
long-term	NULL
incubation	NULL
with	NULL
the	NULL
hormone	NULL
.	NULL

The	NULL
ER-Tax	NULL
cells	NULL
were	NULL
preincubated	NULL
with	NULL
or	NULL
without	NULL
estradiol	NULL
(	NULL
E	NULL
)	NULL
for	NULL
the	NULL
time	NULL
period	NULL
indicated	NULL
.	NULL

Next	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
transfected	NULL
with	NULL
the	NULL
reporter	NULL
plasmids	NULL
p	NULL
(	NULL
HTLV-DLTR-CAT	NULL
(	NULL
3	NULL
pug	NULL
)	NULL
(	NULL
4	NULL
)	NULL
or	NULL
p	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
,	NULL
-CAT	NULL
(	NULL
3	NULL
pg	NULL
)	NULL
(	NULL
B	NULL
)	NULL
and/or	NULL
the	NULL
ER-Tax	NULL
expression	NULL
plasmid	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
where	NULL
indicated	NULL
.	NULL

After	NULL
transfection	NULL
,	NULL
the	NULL
transfected	NULL
cells	NULL
were	NULL
maintained	NULL
for	NULL
40	NULL
to	NULL
48	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
hormone	NULL
;	NULL
a	NULL
CAT	NULL
assay	NULL
was	NULL
subsequently	NULL
performed	NULL
.	NULL

The	NULL
CAT	NULL
assays	NULL
were	NULL
scanned	NULL
and	NULL
the	NULL
CAT	NULL
signal	NULL
was	NULL
400	NULL
~	NULL
300	NULL
200	NULL
arbitrary	NULL
units	NULL
1	NULL
E	NULL
100	NULL
o	NULL
LCA	NULL
(	NULL
HTLV-DLTR-CAT	NULL
o	NULL
a	NULL
Able	NULL
,	NULL
Ik	NULL
TAX	NULL
PROMOTES	NULL
OXIDATIVE	NULL
STRESS	NULL
B	NULL
NF-	NULL
«	NULL
B-CAT	NULL
-E	NULL
800	NULL
-	NULL
A	NULL
-E	NULL
+E	NULL
C	NULL
+E	NULL
T	NULL
600	NULL
-|-i	NULL
arbitrary	NULL
units	NULL
1	NULL
fro	NULL
200	NULL
0	NULL
+4	NULL
quantified	NULL
using	NULL
Adobe	NULL
Photoshop	NULL
(	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
arbitrary	NULL
start	NULL
of	NULL
incubation	NULL
day	NULL
0	NULL
with	NULL
E	NULL
day	NULL
-7	NULL
day	NULL
-30	NULL
start	NULL
of	NULL
incubation	NULL
with	NULL
E	NULL
day	NULL
-30	NULL
day	NULL
0	NULL
day	NULL
-7	NULL
|	NULL
day	NULL
-30	NULL
|	NULL
day-30	NULL
units	NULL
(	NULL
X	NULL
10	NULL
``	NULL
)	NULL
represent	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
spots	NULL
as	NULL
measured	NULL
by	NULL
the	NULL
Scan-analysis	NULL
program	NULL
.	NULL

The	NULL
experiments	NULL
day	NULL
0	NULL
transfection	NULL
with	NULL
:	NULL
LTR-CAT	NULL
day	NULL
0	NULL
transfection	NULL
with	NULL
:	NULL
LTR-CAT	NULL
+ER-Tax	NULL
INF-xB-CAT	NULL
NFxB-CAT	NULL
TPR	NULL
Tak	NULL
were	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

The	NULL
bars	NULL
represent	NULL
SDs	NULL
.	NULL

activity	NULL
for	NULL
=5	NULL
days	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

After	NULL
estradiol	NULL
treatment	NULL
of	NULL
the	NULL
cells	NULL
for	NULL
5	NULL
days	NULL
,	NULL
a	NULL
50-fold	NULL
increase	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B-specific	NULL
band	NULL
compared	NULL
with	NULL
control	NULL
cells	NULL
was	NULL
observed	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
most	NULL
other	NULL
activators	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
Tax-induced	NULL
NF-KB	NULL
activation	NULL
is	NULL
long-lasting	NULL
and	NULL
is	NULL
stable	NULL
for	NULL
>	NULL
5	NULL
days	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
the	NULL
CAT	NULL
ER-ATax	NULL
ER-Tax	NULL
Jurkat	NULL
cells	NULL
Jurkat	NULL
Fold	NULL
|	NULL
_	NULL
|	NULL
no	NULL
[	NULL
soe	NULL
|11	NULL
|	NULL
30	NULL
|	NULL
ao	NULL
|	NULL
1s	NULL
|inoe|	NULL
so	NULL
|	NULL
1s	NULL
|	NULL
1s	NULL
|	NULL
22	NULL
induction	NULL
i	NULL
``	NULL
R	NULL
a	NULL
<	NULL
|=	NULL
|s|s	NULL
|	NULL
s	NULL
3	NULL
|	NULL
f	NULL
Pl	NULL
:	NULL
|f	NULL
+	NULL
I	NULL
”	NULL
.	NULL

woe	NULL
F	NULL
FIGURE	NULL
2	NULL
.	NULL

Kinetics	NULL
of	NULL
the	NULL
hormone-inducible	NULL
Tax-dependent	NULL
induction	NULL
of	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
NF-KB	NULL
.	NULL

The	NULL
ER-Tax-	NULL
or	NULL
ER-ATax-expressing	NULL
Jurkat	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
estradiol	NULL
(	NULL
E	NULL
)	NULL
for	NULL
the	NULL
time	NULL
period	NULL
indicated	NULL
(	NULL
d	NULL
=	NULL
days	NULL
)	NULL
.	NULL

Cells	NULL
that	NULL
had	NULL
been	NULL
stimulated	NULL
with	NULL
PMA	NULL
(	NULL
20	NULL
ng/ml	NULL
)	NULL
and	NULL
PHA	NULL
(	NULL
1	NULL
ug/ml	NULL
!	NULL
)	NULL

for	NULL
1	NULL
h	NULL
were	NULL
used	NULL
as	NULL
positive	NULL
controls	NULL
.	NULL

Total	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
for	NULL
each	NULL
timepoint	NULL
,	NULL
and	NULL
equal	NULL
amounts	NULL
of	NULL
protein	NULL
were	NULL
subjected	NULL
to	NULL
EMSA	NULL
using	NULL
an	NULL
NF-	NULL
«	NULL
B-specific	NULL
oligonucleotide	NULL
.	NULL

The	NULL
position	NULL
of	NULL
the	NULL
specific	NULL
DNA/protein	NULL
complex	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

The	NULL
bands	NULL
were	NULL
scanned	NULL
with	NULL
a	NULL
PhosphorImager	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
the	NULL
intensity	NULL
was	NULL
analyzed	NULL
with	NULL
ImageQuant	NULL
software	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

Fold	NULL
induction	NULL
is	NULL
indicated	NULL
in	NULL
each	NULL
case	NULL
as	NULL
compared	NULL
with	NULL
control	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
hormone	NULL
and	NULL
adjusted	NULL
to	NULL
the	NULL
lower	NULL
unspecific	NULL
band	NULL
.	NULL

assays	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
was	NULL
no	NULL
longer	NULL
detected	NULL
after	NULL
a	NULL
prolonged	NULL
exposure	NULL
(	NULL
1	NULL
mo	NULL
)	NULL
of	NULL
the	NULL
cells	NULL
to	NULL
hormone	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Control	NULL
ER-ATax-expressing	NULL
cells	NULL
were	NULL
not	NULL
able	NULL
to	NULL
induce	NULL
NF-	NULL
«	NULL
B-binding	NULL
activity	NULL
at	NULL
the	NULL
various	NULL
timepoints	NULL
tested	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Tax	NULL
induces	NULL
apoptosis	NULL
that	NULL
is	NULL
blocked	NULL
by	NULL
antioxidants	NULL
We	NULL
subsequently	NULL
analyzed	NULL
the	NULL
viability	NULL
of	NULL
the	NULL
Jurkat	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
exposed	NULL
to	NULL
Tax	NULL
activity	NULL
or	NULL
treated	NULL
with	NULL
moderate	NULL
concentrations	NULL
(	NULL
1	NULL
ug/ml	NULL
!	NULL
)	NULL

of	NULL
anti-CD3	NULL
mAb	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
3	NULL
,	NULL
treating	NULL
ER-Tax-expressing	NULL
Jurkat	NULL
cells	NULL
with	NULL
anti-CD3	NULL
mAb	NULL
alone	NULL
or	NULL
for	NULL
30	NULL
h	NULL
with	NULL
estradiol	NULL
alone	NULL
resulted	NULL
in	NULL
little	NULL
or	NULL
no	NULL
changes	NULL
in	NULL
apoptosis	NULL
(	NULL
DNA	NULL
fragmentation	NULL
)	NULL
as	NULL
measured	NULL
by	NULL
Hoechst	NULL
33342	NULL
stain-ing	NULL
.	NULL

However	NULL
,	NULL
the	NULL
combination	NULL
of	NULL
these	NULL
two	NULL
stimuli	NULL
was	NULL
strongly	NULL
synergistic	NULL
,	NULL
leading	NULL
to	NULL
a	NULL
nearly	NULL
threefold	NULL
increase	NULL
in	NULL
the	NULL
total	NULL
number	NULL
of	NULL
cells	NULL
undergoing	NULL
apoptosis	NULL
compared	NULL
with	NULL
the	NULL
background	NULL
level	NULL
of	NULL
spontaneous	NULL
apoptosis	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

While	NULL
the	NULL
induction	NULL
40	NULL
[	NULL
]	NULL
medium	NULL
T	NULL
M	NULL
anti-CD3	NULL
ie	NULL
30	NULL
wn	NULL
b..	NULL
m	NULL
o	NULL
-	NULL
``	NULL
20	NULL
«	NULL
w	NULL
control	NULL
ADF	NULL
E	NULL
E	NULL
+	NULL
ADF	NULL
-	NULL
PDTC	NULL
-	NULL
PDTC+E	NULL
FIGURE	NULL
3	NULL
.	NULL

Blocking	NULL
of	NULL
Tax	NULL
and/or	NULL
anti-CD3-induced	NULL
apoptosis	NULL
by	NULL
an-tioxidants	NULL
.	NULL

Cells	NULL
expressing	NULL
ER-Tax	NULL
were	NULL
cultured	NULL
for	NULL
30	NULL
h	NULL
with	NULL
ADF	NULL
(	NULL
40	NULL
ug/tol	NULL
)	NULL
alone	NULL
,	NULL
estradiol	NULL
(	NULL
E	NULL
)	NULL
(	NULL
1	NULL
M	NULL
)	NULL
and	NULL
ADF	NULL
,	NULL
PDTC	NULL
(	NULL
5	NULL
mM	NULL
)	NULL
alone	NULL
,	NULL
or	NULL
PDTC	NULL
and	NULL
E	NULL
as	NULL
indicated	NULL
.	NULL

ADF	NULL
and	NULL
PDTC	NULL
were	NULL
added	NULL
15	NULL
min	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
hormone	NULL
.	NULL

Anti-CD3	NULL
mAb	NULL
stimulation	NULL
(	NULL
immobilized	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
1	NULL
pg/ml	NULL
)	NULL
was	NULL
absent	NULL
(	NULL
empty	NULL
bars	NULL
)	NULL
or	NULL
present	NULL
(	NULL
filled	NULL
bars	NULL
)	NULL
for	NULL
the	NULL
same	NULL
time	NULL
period	NULL
.	NULL

After	NULL
30	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
Hoechst	NULL
33342	NULL
and	NULL
PI	NULL
and	NULL
analyzed	NULL
by	NULL
FACS	NULL
analysis	NULL
.	NULL

Cells	NULL
that	NULL
were	NULL
highly	NULL
stained	NULL
with	NULL
Hoechst	NULL
33342	NULL
but	NULL
still	NULL
negative	NULL
for	NULL
PI	NULL
were	NULL
considered	NULL
to	NULL
be	NULL
undergoing	NULL
apoptosis	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
%	NULL
relative	NULL
intracellular	NULL
GSH	NULL
T	NULL
120	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
FIGURE	NULL
4	NULL
.	NULL

-	NULL
Time-dependent	NULL
effect	NULL
of	NULL
Tax	NULL
activity	NULL
on	NULL
intracellular	NULL
GSH	NULL
levels	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
intracellular	NULL
GSH	NULL
content	NULL
are	NULL
shown	NULL
.	NULL

Inducible	NULL
ER-Tax	NULL
fusion	NULL
protein	NULL
(	NULL
C	NULL
)	NULL
was	NULL
activated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
1	NULL
M	NULL
of	NULL
estradiol	NULL
.	NULL

Untransfected	NULL
control	NULL
cells	NULL
(	NULL
&	NULL
)	NULL
and	NULL
ER-ATax-expressing	NULL
cells	NULL
(	NULL
0	NULL
)	NULL
were	NULL
similarly	NULL
treated	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
and	NULL
analyzed	NULL
for	NULL
intracellular	NULL
GSH	NULL
content	NULL
at	NULL
the	NULL
indicated	NULL
time	NULL
intervals	NULL
.	NULL

Next	NULL
,	NULL
cells	NULL
were	NULL
loaded	NULL
with	NULL
MCB	NULL
and	NULL
subjected	NULL
to	NULL
FACS	NULL
analysis	NULL
.	NULL

The	NULL
mean	NULL
values	NULL
obtained	NULL
from	NULL
four	NULL
independent	NULL
experiments	NULL
are	NULL
shown	NULL
together	NULL
with	NULL
the	NULL
variation	NULL
from	NULL
the	NULL
mean	NULL
.	NULL

The	NULL
fluorescence	NULL
intensity	NULL
of	NULL
the	NULL
unstimulated	NULL
cells	NULL
is	NULL
given	NULL
as	NULL
100	NULL
%	NULL
.	NULL

of	NULL
apoptosis	NULL
by	NULL
a	NULL
combination	NULL
of	NULL
anti-CD3	NULL
and	NULL
hormone	NULL
was	NULL
already	NULL
detectable	NULL
in	NULL
ER-Tax	NULL
Jurkat	NULL
cells	NULL
at	NULL
8	NULL
h	NULL
after	NULL
treatment	NULL
,	NULL
no	NULL
significant	NULL
changes	NULL
in	NULL
the	NULL
number	NULL
of	NULL
apoptotic	NULL
cells	NULL
were	NULL
observed	NULL
for	NULL
=30	NULL
h	NULL
posttreatment	NULL
in	NULL
control	NULL
ER-ATax	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
apoptosis	NULL
observed	NULL
in	NULL
TCR-stimulated	NULL
cells	NULL
could	NULL
clearly	NULL
be	NULL
attributed	NULL
to	NULL
Tax	NULL
activity	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
role	NULL
of	NULL
the	NULL
intracellular	NULL
redox	NULL
state	NULL
in	NULL
Tax-mediated	NULL
apoptosis	NULL
,	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
antioxidants	NULL
before	NULL
hormone	NULL
and	NULL
anti-CD3	NULL
.	NULL

Thioredoxin	NULL
(	NULL
ADF	NULL
)	NULL
,	NULL
which	NULL
is	NULL
a	NULL
potent	NULL
3053	NULL
physiologic	NULL
antioxidative	NULL
protein	NULL
that	NULL
is	NULL
able	NULL
to	NULL
be	NULL
secreted	NULL
and	NULL
taken	NULL
up	NULL
by	NULL
various	NULL
cells	NULL
(	NULL
20	NULL
,	NULL
25	NULL
,	NULL
26	NULL
)	NULL
,	NULL
strongly	NULL
inhibited	NULL
Tax-induced	NULL
apoptosis	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Pyrrolidine	NULL
dithiocarbamate	NULL
(	NULL
PDTC	NULL
)	NULL
,	NULL
which	NULL
is	NULL
an	NULL
iron	NULL
chelator	NULL
and	NULL
radical	NULL
scavenger	NULL
,	NULL
was	NULL
slightly	NULL
less	NULL
effective	NULL
.	NULL

In	NULL
ADF-treated	NULL
cells	NULL
,	NULL
viability	NULL
was	NULL
even	NULL
moderately	NULL
increased	NULL
compared	NULL
with	NULL
control	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
antioxidants	NULL
can	NULL
block	NULL
Tax-induced	NULL
apoptotic	NULL
cell	NULL
death	NULL
.	NULL

Tax	NULL
induces	NULL
a	NULL
prooxidant	NULL
state	NULL
in	NULL
T	NULL
cells	NULL
Since	NULL
antioxidants	NULL
can	NULL
prevent	NULL
Tax-induced	NULL
apoptosis	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
Tax	NULL
has	NULL
an	NULL
effect	NULL
on	NULL
the	NULL
cellular	NULL
redox	NULL
state	NULL
.	NULL

Jurkat	NULL
cells	NULL
stably	NULL
expressing	NULL
a	NULL
hormone-inducible	NULL
Tax	NULL
fusion	NULL
protein	NULL
(	NULL
ER-Tax	NULL
)	NULL
were	NULL
treated	NULL
for	NULL
various	NULL
times	NULL
with	NULL
estradiol	NULL
.	NULL

Untransfected	NULL
cells	NULL
or	NULL
cells	NULL
expressing	NULL
ER-ATax	NULL
were	NULL
used	NULL
as	NULL
controls	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
the	NULL
ER-Tax	NULL
fusion	NULL
protein	NULL
resulted	NULL
in	NULL
an	NULL
immediate	NULL
(	NULL
15	NULL
min	NULL
postinduction	NULL
)	NULL
drop	NULL
in	NULL
the	NULL
intracellular	NULL
amount	NULL
of	NULL
GSH	NULL
and	NULL
in	NULL
considerably	NULL
reduced	NULL
levels	NULL
within	NULL
2	NULL
h	NULL
after	NULL
Tax	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

A	NULL
slow	NULL
recovery	NULL
of	NULL
the	NULL
GSH	NULL
levels	NULL
approaching	NULL
the	NULL
levels	NULL
seen	NULL
for	NULL
control	NULL
cells	NULL
was	NULL
seen	NULL
at	NULL
5	NULL
days	NULL
after	NULL
the	NULL
beginning	NULL
of	NULL
estradiol	NULL
treatment	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
untransfected	NULL
or	NULL
control	NULL
ER-ATax	NULL
Jurkat	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
treated	NULL
with	NULL
estradiol	NULL
did	NULL
not	NULL
show	NULL
any	NULL
decrease	NULL
in	NULL
intracellular	NULL
GSH	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

ER-Tax	NULL
Jurkat	NULL
cells	NULL
that	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
hormone	NULL
for	NULL
a	NULL
prolonged	NULL
period	NULL
of	NULL
time	NULL
(	NULL
1	NULL
mo	NULL
)	NULL
showed	NULL
normal	NULL
levels	NULL
of	NULL
GSH	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
the	NULL
above	NULL
observations	NULL
,	NULL
intracellular	NULL
H	NULL
,	NULL
O	NULL
,	NULL
levels	NULL
were	NULL
measured	NULL
at	NULL
2	NULL
h	NULL
after	NULL
ER-Tax	NULL
or	NULL
ER-ATax	NULL
Jurkat	NULL
cells	NULL
had	NULL
been	NULL
treated	NULL
with	NULL
hormone	NULL
.	NULL

The	NULL
treatment	NULL
of	NULL
ER-Tax	NULL
Jurkat	NULL
cells	NULL
with	NULL
estradiol	NULL
led	NULL
to	NULL
a	NULL
marked	NULL
increase	NULL
in	NULL
the	NULL
intracellular	NULL
levels	NULL
of	NULL
H	NULL
,	NULL
O	NULL
,	NULL
and	NULL
a	NULL
concomitant	NULL
decrease	NULL
of	NULL
GSH	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
A	NULL
and	NULL
D	NULL
)	NULL
.	NULL

The	NULL
Tax-mediated	NULL
prooxidant	NULL
state	NULL
was	NULL
inhibited	NULL
by	NULL
pretreating	NULL
the	NULL
cells	NULL
with	NULL
ADF	NULL
or	NULL
PDTC	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
A	NULL
and	NULL
D	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
Tax-induced	NULL
(	NULL
A	NULL
|	NULL
ER-Tax	NULL
200	NULL
FIGURE	NULL
5	NULL
.	NULL

Effect	NULL
of	NULL
Tax	NULL
and/or	NULL
CD3/TCR	NULL
stimulation	NULL
on	NULL
intracellular	NULL
H	NULL
,	NULL
O	NULL
,	NULL
and	NULL
GSH	NULL
levels	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
prooxidant	NULL
changes	NULL
after	NULL
the	NULL
activation	NULL
of	NULL
Tax	NULL
and/or	NULL
TCR	NULL
is	NULL
shown	NULL
.	NULL

Jurkat	NULL
cells	NULL
expressing	NULL
ER-Tax	NULL
or	NULL
ER-ATax	NULL
were	NULL
activated	NULL
for	NULL
2	NULL
h	NULL
with	NULL
1	NULL
gM	NULL
of	NULL
estradiol	NULL
(	NULL
E	NULL
)	NULL
.	NULL

A	NULL
,	NULL
At	NULL
15	NULL
min	NULL
before	NULL
stimulation	NULL
with	NULL
the	NULL
hormone	NULL
,	NULL
human	NULL
recombinant	NULL
ADF	NULL
(	NULL
40	NULL
ug/ml	NULL
!	NULL
)	NULL

or	NULL
PDTC	NULL
(	NULL
5	NULL
mM	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
cultures	NULL
as	NULL
indicated	NULL
.	NULL

B	NULL
and	NULL
C	NULL
,	NULL
Cells	NULL
50	NULL
%	NULL
relative	NULL
intracellular	NULL
H307	NULL
§	NULL
ER-ATax	NULL
|B	NULL
|	NULL
ER-Tax	NULL
A	NULL
200	NULL
200	NULL
150	NULL
150	NULL
&	NULL
50	NULL
were	NULL
stimulated	NULL
with	NULL
coated	NULL
anti-CD3	NULL
0	NULL
7	NULL
mAb	NULL
(	NULL
1	NULL
ug/ml	NULL
!	NULL
)	NULL

for	NULL
2	NULL
h	NULL
and	NULL
incubated	NULL
control	NULL
|	NULL
E	NULL
__	NULL
app	NULL
control	NULL
_	NULL
E	NULL
_	NULL
anti-CD3	NULL
amEEm	NULL
sunlint	NULL
OE	NULL
lops	NULL
nulls-	NULL
(	NULL
tn	NULL
!	NULL

simultaneously	NULL
with	NULL
or	NULL
without	NULL
hor-D	NULL
|	NULL
ER-Tax	NULL
mone	NULL
as	NULL
indicated	NULL
.	NULL

Cells	NULL
were	NULL
loaded	NULL
with	NULL
DCFH	NULL
for	NULL
45	NULL
min	NULL
,	NULL
and	NULL
H	NULL
,	NULL
O	NULL
,	NULL
was	NULL
measured	NULL
by	NULL
FACS	NULL
.	NULL

D	NULL
,	NULL
At	NULL
15	NULL
min	NULL
before	NULL
stimulation	NULL
with	NULL
estradiol	NULL
,	NULL
ADF	NULL
(	NULL
40	NULL
ug/ml	NULL
)	NULL
or	NULL
PDTC	NULL
(	NULL
5	NULL
uM	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
cultures	NULL
as	NULL
indicated	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
loaded	NULL
with	NULL
MCB	NULL
,	NULL
and	NULL
the	NULL
GSH	NULL
level	NULL
was	NULL
measured	NULL
by	NULL
FACS	NULL
analysis	NULL
.	NULL

The	NULL
mean	NULL
values	NULL
collected	NULL
from	NULL
four	NULL
independent	NULL
experiments	NULL
are	NULL
shown	NULL
with	NULL
the	NULL
variation	NULL
from	NULL
the	NULL
mean	NULL
.	NULL

The	NULL
mean	NULL
fluorescence	NULL
intensity	NULL
of	NULL
the	NULL
control	NULL
0	NULL
was	NULL
considered	NULL
to	NULL
be	NULL
100	NULL
%	NULL
.	NULL

%	NULL
relative	NULL
intracellular	NULL
GSH	NULL
&	NULL
j	NULL
E+	NULL
control	NULL
E	NULL
ADF	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
3054	NULL
prooxidant	NULL
state	NULL
as	NULL
well	NULL
as	NULL
apoptosis	NULL
can	NULL
be	NULL
blocked	NULL
by	NULL
antioxi-dants	NULL
.	NULL

These	NULL
observations	NULL
indicate	NULL
that	NULL
enhanced	NULL
prooxidant	NULL
conditions	NULL
play	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
T	NULL
cell	NULL
apoptosis	NULL
by	NULL
HTLV-I	NULL
Tax	NULL
.	NULL

Tax	NULL
and	NULL
CD3/TCR-mediated	NULL
signals	NULL
synergize	NULL
in	NULL
inducing	NULL
a	NULL
prooxidant	NULL
state	NULL
The	NULL
CD3/TCR	NULL
complex	NULL
and	NULL
Tax	NULL
reportedly	NULL
cooperate	NULL
in	NULL
inducing	NULL
activation-associated	NULL
events	NULL
in	NULL
T	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
activation-induced	NULL
apoptosis	NULL
(	NULL
11-13	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
individual	NULL
and	NULL
combined	NULL
effects	NULL
of	NULL
these	NULL
two	NULL
independent	NULL
stimuli	NULL
on	NULL
the	NULL
intracellular	NULL
redox	NULL
state	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
examined	NULL
.	NULL

In	NULL
response	NULL
to	NULL
treatment	NULL
with	NULL
immobilized	NULL
anti-CD3	NULL
mAb	NULL
alone	NULL
,	NULL
both	NULL
ER-Tax-	NULL
or	NULL
control	NULL
ER-ATax-expressing	NULL
cells	NULL
exhibited	NULL
a	NULL
comparable	NULL
increase	NULL
in	NULL
the	NULL
intracellular	NULL
concentration	NULL
of	NULL
H	NULL
,	NULL
O	NULL
,	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
estradiol	NULL
alone	NULL
enhanced	NULL
the	NULL
intracellular	NULL
H	NULL
,	NULL
O	NULL
,	NULL
in	NULL
the	NULL
ER-Tax	NULL
cells	NULL
,	NULL
while	NULL
no	NULL
such	NULL
increase	NULL
was	NULL
seen	NULL
in	NULL
the	NULL
ER-ATax	NULL
Jurkat	NULL
cells	NULL
.	NULL

Treatment	NULL
with	NULL
anti-CD3	NULL
mAb	NULL
and	NULL
estradiol	NULL
led	NULL
to	NULL
an	NULL
additive	NULL
enhancement	NULL
of	NULL
intracellular	NULL
H	NULL
,	NULL
O	NULL
,	NULL
in	NULL
ER-Tax	NULL
Jurkat	NULL
cells	NULL
,	NULL
but	NULL
no	NULL
enhancement	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
control	NULL
ER-ATax	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

While	NULL
only	NULL
transient	NULL
changes	NULL
(	NULL
lasting	NULL
for	NULL
a	NULL
few	NULL
hours	NULL
)	NULL
were	NULL
observed	NULL
in	NULL
the	NULL
intracellular	NULL
levels	NULL
of	NULL
H	NULL
,	NULL
O	NULL
,	NULL
when	NULL
anti-CD3	NULL
mAb	NULL
was	NULL
used	NULL
,	NULL
the	NULL
changes	NULL
that	NULL
were	NULL
induced	NULL
by	NULL
hormone	NULL
activation	NULL
of	NULL
ER-Tax	NULL
were	NULL
sustained	NULL
and	NULL
lasted	NULL
for	NULL
several	NULL
days	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
observation	NULL
highlights	NULL
the	NULL
chronic	NULL
nature	NULL
of	NULL
the	NULL
activation	NULL
events	NULL
that	NULL
are	NULL
mediated	NULL
by	NULL
Tax	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
transient	NULL
effects	NULL
that	NULL
are	NULL
seen	NULL
in	NULL
response	NULL
to	NULL
TCR	NULL
stimulation	NULL
.	NULL

Discussion	NULL
Our	NULL
experiments	NULL
indicate	NULL
that	NULL
Jurkat	NULL
T	NULL
cells	NULL
stably	NULL
expressing	NULL
ER-Tax	NULL
exhibit	NULL
hormone-inducible	NULL
Tax	NULL
activity	NULL
upon	NULL
a	NULL
short-term	NULL
exposure	NULL
to	NULL
estradiol	NULL
.	NULL

A	NULL
long-term	NULL
exposure	NULL
to	NULL
hormone	NULL
(	NULL
>	NULL
30	NULL
days	NULL
)	NULL
leads	NULL
to	NULL
an	NULL
apparent	NULL
unresponsiveness	NULL
.	NULL

The	NULL
unresponsiveness	NULL
is	NULL
not	NULL
due	NULL
to	NULL
changes	NULL
in	NULL
the	NULL
inherent	NULL
properties	NULL
of	NULL
the	NULL
cells	NULL
,	NULL
as	NULL
a	NULL
new	NULL
transfection	NULL
with	NULL
ER-Tax	NULL
was	NULL
able	NULL
to	NULL
reestablish	NULL
hormone-depen-dence	NULL
.	NULL

One	NULL
likely	NULL
explanation	NULL
is	NULL
that	NULL
cells	NULL
that	NULL
are	NULL
defective	NULL
in	NULL
Tax	NULL
activity	NULL
have	NULL
a	NULL
growth	NULL
advantage	NULL
and	NULL
are	NULL
selected	NULL
upon	NULL
the	NULL
continuous	NULL
exposure	NULL
of	NULL
cultures	NULL
to	NULL
hormone	NULL
.	NULL

The	NULL
early	NULL
and	NULL
late	NULL
effects	NULL
of	NULL
Tax	NULL
activation	NULL
in	NULL
the	NULL
Tax-expressing	NULL
Jurkat	NULL
cells	NULL
can	NULL
be	NULL
quite	NULL
different	NULL
.	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
previously	NULL
that	NULL
NF-KB	NULL
activity	NULL
could	NULL
not	NULL
be	NULL
detected	NULL
in	NULL
the	NULL
nucleus	NULL
following	NULL
a	NULL
long-term	NULL
expression	NULL
of	NULL
Tax	NULL
in	NULL
Jurkat	NULL
T	NULL
lymphocytes	NULL
(	NULL
27	NULL
)	NULL
.	NULL

In	NULL
this	NULL
case	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
mi-togens	NULL
and	NULL
cytokines	NULL
to	NULL
induce	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
was	NULL
also	NULL
blocked	NULL
.	NULL

It	NULL
seems	NULL
that	NULL
the	NULL
NF-	NULL
«	NULL
B-signaling	NULL
pathway	NULL
was	NULL
impaired	NULL
in	NULL
the	NULL
latter	NULL
study	NULL
,	NULL
since	NULL
Tax	NULL
was	NULL
active	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
other	NULL
transcription	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
Fos	NULL
and	NULL
Jun	NULL
,	NULL
was	NULL
unaffected	NULL
.	NULL

However	NULL
,	NULL
our	NULL
results	NULL
suggest	NULL
a	NULL
selection	NULL
against	NULL
Tax	NULL
activity	NULL
following	NULL
the	NULL
prolonged	NULL
activation	NULL
of	NULL
this	NULL
protein	NULL
rather	NULL
than	NULL
a	NULL
suppression	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
observations	NULL
indicate	NULL
that	NULL
T	NULL
cells	NULL
may	NULL
not	NULL
be	NULL
able	NULL
to	NULL
tolerate	NULL
the	NULL
intracellular	NULL
constitutive	NULL
expression	NULL
of	NULL
Tax	NULL
for	NULL
prolonged	NULL
time	NULL
periods	NULL
.	NULL

This	NULL
intolerance	NULL
may	NULL
explain	NULL
the	NULL
apparent	NULL
shut	NULL
down	NULL
of	NULL
Tax	NULL
expression	NULL
in	NULL
HTLV-T-infected	NULL
leukemic	NULL
T	NULL
cells	NULL
.	NULL

Our	NULL
posttranslational	NULL
inducible	NULL
system	NULL
allowed	NULL
a	NULL
careful	NULL
kinetic	NULL
analysis	NULL
both	NULL
of	NULL
the	NULL
Tax-mediated	NULL
effects	NULL
and	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
previously	NULL
that	NULL
one	NULL
of	NULL
the	NULL
early	NULL
effects	NULL
of	NULL
Tax	NULL
function	NULL
is	NULL
activation-induced	NULL
T	NULL
cell	NULL
apoptosis	NULL
(	NULL
13	NULL
)	NULL
.	NULL

The	NULL
observations	NULL
that	NULL
we	NULL
report	NULL
here	NULL
indicate	NULL
that	NULL
HTLV-I	NULL
Tax	NULL
mediates	NULL
oxidative	NULL
stress	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
may	NULL
subsequently	NULL
activate	NULL
NF-KB	NULL
,	NULL
a	NULL
prooxidant-inducible	NULL
transcription	NULL
factor	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
has	NULL
been	NULL
recently	NULL
linked	NULL
to	NULL
apoptosis	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
plays	NULL
either	NULL
an	NULL
an-tiapoptotic	NULL
or	NULL
a	NULL
proapoptotic	NULL
role	NULL
,	NULL
and	NULL
the	NULL
role	NULL
that	NULL
is	NULL
chosen	NULL
may	NULL
TAX	NULL
PROMOTES	NULL
OXIDATIVE	NULL
STRESS	NULL
depend	NULL
upon	NULL
the	NULL
cell	NULL
type	NULL
,	NULL
subunit	NULL
composition	NULL
,	NULL
or	NULL
duration	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
response	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

28	NULL
)	NULL
.	NULL

In	NULL
our	NULL
study	NULL
,	NULL
apoptotic	NULL
cell	NULL
death	NULL
in	NULL
Jurkat	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
induced	NULL
by	NULL
Tax	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
accompanied	NULL
by	NULL
NF-B	NULL
activation	NULL
.	NULL

The	NULL
duration	NULL
of	NULL
Tax	NULL
stimulation	NULL
determines	NULL
the	NULL
intensity	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
and	NULL
oxidative	NULL
stress	NULL
and	NULL
the	NULL
severity	NULL
of	NULL
the	NULL
antiproliferative	NULL
effect	NULL
.	NULL

This	NULL
finding	NULL
may	NULL
be	NULL
related	NULL
in	NULL
part	NULL
to	NULL
the	NULL
persistence	NULL
of	NULL
a	NULL
prooxidative	NULL
state	NULL
and	NULL
to	NULL
a	NULL
prolonged	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Transactivation	NULL
and	NULL
DNA-binding	NULL
studies	NULL
revealed	NULL
that	NULL
Tax	NULL
activity	NULL
induces	NULL
a	NULL
long-lasting	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
rather	NULL
than	NULL
a	NULL
transient	NULL
one	NULL
as	NULL
has	NULL
been	NULL
shown	NULL
for	NULL
several	NULL
chemical	NULL
and	NULL
physiologic	NULL
stimuli	NULL
of	NULL
NFE-	NULL
«	NULL
B	NULL
(	NULL
27	NULL
,	NULL
29	NULL
)	NULL
.	NULL

The	NULL
strong	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
was	NULL
entirely	NULL
due	NULL
to	NULL
the	NULL
induced	NULL
Tax	NULL
protein	NULL
and	NULL
not	NULL
to	NULL
a	NULL
direct	NULL
response	NULL
of	NULL
the	NULL
cells	NULL
to	NULL
hormone	NULL
,	NULL
as	NULL
control	NULL
ER-ATax-expressing	NULL
cells	NULL
did	NULL
not	NULL
show	NULL
any	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
after	NULL
being	NULL
exposed	NULL
to	NULL
estradiol	NULL
.	NULL

Therefore	NULL
,	NULL
as	NULL
previously	NULL
proposed	NULL
for	NULL
apoptosis	NULL
triggered	NULL
by	NULL
serum	NULL
withdrawal	NULL
(	NULL
30	NULL
)	NULL
,	NULL
the	NULL
unusually	NULL
persistent	NULL
Tax-induced	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
may	NULL
exert	NULL
a	NULL
proapoptotic	NULL
function	NULL
in	NULL
our	NULL
experimental	NULL
system	NULL
.	NULL

A	NULL
short-term	NULL
hormone	NULL
induction	NULL
of	NULL
ER-Tax	NULL
in	NULL
Jurkat	NULL
cells	NULL
together	NULL
with	NULL
the	NULL
stimulation	NULL
of	NULL
TCR	NULL
promotes	NULL
apoptotic	NULL
cell	NULL
death	NULL
(	NULL
13	NULL
)	NULL
.	NULL

The	NULL
apoptosis-promoting	NULL
effect	NULL
of	NULL
Tax	NULL
is	NULL
particularly	NULL
evident	NULL
when	NULL
low	NULL
concentrations	NULL
of	NULL
anti-CD3	NULL
are	NULL
used	NULL
.	NULL

Tax	NULL
is	NULL
also	NULL
able	NULL
to	NULL
induce	NULL
apoptosis	NULL
in	NULL
Rat-1	NULL
fibroblasts	NULL
,	NULL
and	NULL
this	NULL
apoptosis	NULL
is	NULL
blocked	NULL
by	NULL
the	NULL
Bcl-2	NULL
protein	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
Bcel-2	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
function	NULL
in	NULL
an	NULL
antioxidant	NULL
pathway	NULL
to	NULL
prevent	NULL
apoptosis	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
intracellular	NULL
prooxidant	NULL
conditions	NULL
reportedly	NULL
induce	NULL
apoptosis	NULL
in	NULL
several	NULL
instances	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

32	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
provide	NULL
evidence	NULL
that	NULL
the	NULL
mediator	NULL
of	NULL
apoptosis	NULL
,	NULL
Tax	NULL
,	NULL
can	NULL
induce	NULL
prooxidant	NULL
conditions	NULL
in	NULL
the	NULL
cell	NULL
.	NULL

This	NULL
is	NULL
revealed	NULL
by	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
intracellular	NULL
GSH	NULL
level	NULL
that	NULL
occurs	NULL
rapidly	NULL
(	NULL
within	NULL
15	NULL
min	NULL
)	NULL
and	NULL
lasts	NULL
for	NULL
several	NULL
days	NULL
.	NULL

The	NULL
decrease	NULL
in	NULL
the	NULL
intracellular	NULL
GSH	NULL
level	NULL
is	NULL
accompanied	NULL
by	NULL
a	NULL
Tax-mediated	NULL
increase	NULL
of	NULL
intracellular	NULL
H	NULL
,	NULL
O	NULL
,	NULL
levels	NULL
.	NULL

The	NULL
long-lasting	NULL
,	NULL
Tax-induced	NULL
prooxidant	NULL
state	NULL
correlated	NULL
with	NULL
the	NULL
observed	NULL
apoptosis	NULL
and	NULL
NF-KB	NULL
activation	NULL
.	NULL

Tax-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
can	NULL
be	NULL
blocked	NULL
by	NULL
antioxidants	NULL
(	NULL
19	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Tax-induced	NULL
apoptosis	NULL
can	NULL
be	NULL
prevented	NULL
by	NULL
radical	NULL
scavengers	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
Tax	NULL
activity	NULL
induces	NULL
a	NULL
prooxidant	NULL
state	NULL
in	NULL
the	NULL
cell	NULL
shows	NULL
that	NULL
Tax	NULL
uses	NULL
common	NULL
pathways	NULL
to	NULL
induce	NULL
cellular	NULL
activation	NULL
and	NULL
apoptosis	NULL
.	NULL

Since	NULL
ROIs	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
CD95	NULL
ligand	NULL
(	NULL
CD95L	NULL
)	NULL
mRNA	NULL
expression	NULL
in	NULL
some	NULL
cases	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
,	NULL
this	NULL
involvement	NULL
could	NULL
explain	NULL
the	NULL
mechanism	NULL
underlying	NULL
the	NULL
Tax-induced	NULL
up-regulation	NULL
of	NULL
CD95L	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
it	NULL
has	NULL
been	NULL
recently	NULL
shown	NULL
that	NULL
prooxidant-induced	NULL
NF-KB	NULL
activation	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
CD95L	NULL
gene	NULL
(	NULL
34	NULL
,	NULL
35	NULL
)	NULL
.	NULL

Tax	NULL
can	NULL
transactivate	NULL
the	NULL
antioxidative	NULL
stress	NULL
protein	NULL
ADF/thi-oredoxin	NULL
(	NULL
36	NULL
)	NULL
.	NULL

ADF	NULL
is	NULL
a	NULL
stress-inducible	NULL
protein	NULL
that	NULL
is	NULL
secreted	NULL
from	NULL
cells	NULL
;	NULL
this	NULL
protein	NULL
plays	NULL
an	NULL
essential	NULL
role	NULL
in	NULL
cellular	NULL
protection	NULL
against	NULL
oxidative	NULL
stress	NULL
and	NULL
cell	NULL
death	NULL
and	NULL
is	NULL
itself	NULL
induced	NULL
by	NULL
various	NULL
oxidative	NULL
agents	NULL
(	NULL
37	NULL
)	NULL
.	NULL

The	NULL
present	NULL
work	NULL
provides	NULL
direct	NULL
evidence	NULL
for	NULL
the	NULL
production	NULL
of	NULL
ROIs	NULL
by	NULL
Tax	NULL
and	NULL
the	NULL
involvement	NULL
of	NULL
these	NULL
intermediates	NULL
in	NULL
Tax-induced	NULL
apoptotic	NULL
T	NULL
cell	NULL
death	NULL
.	NULL

Our	NULL
findings	NULL
suggest	NULL
that	NULL
changes	NULL
in	NULL
the	NULL
intracellular	NULL
redox	NULL
status	NULL
may	NULL
be	NULL
a	NULL
critical	NULL
factor	NULL
in	NULL
Tax-mediated	NULL
DNA	NULL
damage	NULL
and	NULL
apoptosis	NULL
and	NULL
in	NULL
the	NULL
apparent	NULL
shut	NULL
down	NULL
of	NULL
Tax	NULL
expression	NULL
in	NULL
HTLV-I-infected	NULL
cells	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Profs	NULL
.	NULL

Junji	NULL
Yodoi	NULL
and	NULL
Takashi	NULL
Uchiyama	NULL
and	NULL
Drs	NULL
.	NULL

Niki	NULL
Kara-gianni	NULL
and	NULL
Meinrad	NULL
Busslinger	NULL
for	NULL
their	NULL
advice	NULL
,	NULL
interest	NULL
,	NULL
and	NULL
encouragement	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
References	NULL
1	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

Hinuma	NULL
,	NULL
Y.	NULL
,	NULL
K.	NULL
Nagata	NULL
,	NULL
M.	NULL
Hanaoka	NULL
,	NULL
M.	NULL
Nakai	NULL
,	NULL
T.	NULL
Matsumoto	NULL
,	NULL
K.	NULL
I.	NULL
Kinoshita	NULL
,	NULL
S.	NULL
Shirakawa	NULL
,	NULL
and	NULL
I.	NULL
Miyoshi	NULL
.	NULL

1981	NULL
.	NULL

Adult	NULL
T-cell	NULL
leukemia	NULL
:	NULL
antigen	NULL
in	NULL
an	NULL
ATL	NULL
cell	NULL
line	NULL
and	NULL
detection	NULL
of	NULL
antibodies	NULL
to	NULL
the	NULL
antigen	NULL
in	NULL
human	NULL
sera	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
78:6476.	NULL
.	NULL

Poiesz	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
F.	NULL
W.	NULL
Ruscetti	NULL
,	NULL
A.	NULL
F.	NULL
Gazdar	NULL
,	NULL
P.	NULL
A.	NULL
Bunn	NULL
,	NULL
J.	NULL
D.	NULL
Minna	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Gallo	NULL
.	NULL

1980	NULL
.	NULL

Detection	NULL
and	NULL
isolation	NULL
of	NULL
type	NULL
C	NULL
retrovirus	NULL
particles	NULL
from	NULL
fresh	NULL
and	NULL
cultured	NULL
lymphocytes	NULL
of	NULL
a	NULL
patient	NULL
with	NULL
cutaneous	NULL
T-cell	NULL
lymphoma	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
77:7415.	NULL
.	NULL

Uchiyama	NULL
,	NULL
T.	NULL
,	NULL
J.	NULL
Yodoi	NULL
,	NULL
K.	NULL
Sagawa	NULL
,	NULL
K.	NULL
Takatsuki	NULL
,	NULL
and	NULL
H.	NULL
Uchino	NULL
.	NULL

1977	NULL
.	NULL

Adult	NULL
T-cell	NULL
leukemia	NULL
:	NULL
clinical	NULL
and	NULL
hematologic	NULL
features	NULL
of	NULL
16	NULL
cases	NULL
.	NULL

Blood	NULL
50:481.	NULL
.	NULL

Yodoi	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
T.	NULL
Uchiyama	NULL
.	NULL

1992	NULL
.	NULL

Diseases	NULL
associated	NULL
with	NULL
HTLV-I	NULL
:	NULL
virus	NULL
,	NULL
IL-2	NULL
receptor	NULL
dysregulation	NULL
,	NULL
and	NULL
redox	NULL
regulation	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
13:405.	NULL
.	NULL

Seiki	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
Hattori	NULL
,	NULL
Y.	NULL
Hirayama	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1983	NULL
.	NULL

Human	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
:	NULL
complete	NULL
nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
provirus	NULL
genome	NULL
integrated	NULL
in	NULL
leukemia	NULL
cell	NULL
DNA	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
80:3618.	NULL
.	NULL

Yoshida	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
Fujisawa	NULL
,	NULL
J.	NULL
Inoue	NULL
,	NULL
and	NULL
M.	NULL
Seiki	NULL
.	NULL

1986	NULL
.	NULL

Mechanism	NULL
of	NULL
the	NULL
gene	NULL
expression	NULL
of	NULL
HTLV-I	NULL
and	NULL
its	NULL
association	NULL
with	NULL
ATL	NULL
.	NULL

AIDS	NULL
Res	NULL
.	NULL

1:871.	NULL
.	NULL

Ressler	NULL
,	NULL
S.	NULL
,	NULL
L.	NULL
M.	NULL
Connor	NULL
,	NULL
and	NULL
S.	NULL
J.	NULL
Marriott	NULL
.	NULL

1996	NULL
.	NULL

Cellular	NULL
transformation	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I.	NULL
FEMS	NULL
Microbiol	NULL
.	NULL

Lett	NULL
.	NULL

140:99.	NULL
.	NULL

Inoue	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Seiki	NULL
,	NULL
T.	NULL
Taniguchi	NULL
,	NULL
S.	NULL
Tsuru	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1986	NULL
.	NULL

Induction	NULL
of	NULL
interleukin	NULL
2	NULL
receptor	NULL
gene	NULL
expression	NULL
by	NULL
p40x	NULL
encoded	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

5:2883.	NULL
.	NULL

Yodoi	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
T.	NULL
Uchiyama	NULL
.	NULL

1986	NULL
.	NULL

IL-2	NULL
receptor	NULL
dysfunction	NULL
and	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

92:135	NULL
.	NULL

Cross	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
M.	NULL
B.	NULL
Feinberg	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
Wolf	NULL
,	NULL
N.	NULL
J.	NULL
Holbrook	NULL
,	NULL
F.	NULL
Wong-Staal	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1987	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
human	NULL
interleukin-2	NULL
receptor	NULL
-chain	NULL
promoter	NULL
:	NULL
activation	NULL
of	NULL
a	NULL
nonfunctional	NULL
promoter	NULL
by	NULL
the	NULL
transactivator	NULL
gene	NULL
of	NULL
HTLV-I	NULL
.	NULL

Cell	NULL
49:47	NULL
.	NULL

Maruyama	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Shibuya	NULL
,	NULL
H.	NULL
Harada	NULL
,	NULL
M.	NULL
Hatakeyama	NULL
,	NULL
M.	NULL
Seiki	NULL
,	NULL
T.	NULL
Fujita	NULL
,	NULL
J.	NULL
Inoue	NULL
,	NULL
M.	NULL
Yoshida	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1987	NULL
.	NULL

Evidence	NULL
for	NULL
aberrant	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
autocrine	NULL
loop	NULL
by	NULL
HTLV-1-encoded	NULL
p40x	NULL
and	NULL
T3/Ti	NULL
complex	NULL
triggering	NULL
.	NULL

Cell	NULL
48:343	NULL
.	NULL

Akagi	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
K.	NULL
Shimotohno	NULL
.	NULL

1993	NULL
.	NULL

Proliferative	NULL
response	NULL
of	NULL
Tax1-transduced	NULL
primary	NULL
human	NULL
T-cells	NULL
to	NULL
anti-CD3	NULL
antibody	NULL
stimulation	NULL
by	NULL
an	NULL
interleukin-2-independent	NULL
pathway	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:1211	NULL
.	NULL

Chlichlia	NULL
,	NULL
K.	NULL
,	NULL
G.	NULL
Moldenhauer	NULL
,	NULL
P.	NULL
T.	NULL
Daniel	NULL
,	NULL
M.	NULL
Busslinger	NULL
,	NULL
L.	NULL
Gazzolo	NULL
,	NULL
V.	NULL
Schirrmacher	NULL
,	NULL
and	NULL
K.	NULL
Khazaie	NULL
.	NULL

1995	NULL
.	NULL

Immediate	NULL
effects	NULL
of	NULL
reversible	NULL
HTLV-1	NULL
tax	NULL
function	NULL
:	NULL
T-cell	NULL
activation	NULL
and	NULL
apoptosis	NULL
.	NULL

Oncogene	NULL
10:269	NULL
.	NULL

Chlichlia	NULL
,	NULL
K.	NULL
,	NULL
M.	NULL
Busslinger	NULL
,	NULL
M.	NULL
E.	NULL
Peter	NULL
,	NULL
H.	NULL
Walczak	NULL
,	NULL
P.	NULL
H.	NULL
Krammer	NULL
,	NULL
V.	NULL
Schirmacher	NULL
,	NULL
and	NULL
K.	NULL
Khazaic	NULL
.	NULL

1997	NULL
.	NULL

ICB-proteases	NULL
mediated	NULL
HTLV-I	NULL
Tax-induced	NULL
apoptotic	NULL
T-cell	NULL
death	NULL
.	NULL

Oncogene	NULL
14:2265	NULL
.	NULL

Yamada	NULL
,	NULL
T.	NULL
,	NULL
S.	NULL
Yamaoka	NULL
,	NULL
T.	NULL
Goto	NULL
,	NULL
M.	NULL
Nakai	NULL
,	NULL
Y.	NULL
Tsujimoto	NULL
,	NULL
and	NULL
M.	NULL
Hatanaka	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
protein	NULL
induces	NULL
apoptosis	NULL
which	NULL
is	NULL
blocked	NULL
by	NULL
the	NULL
bel-2	NULL
protein	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:3374	NULL
.	NULL

McGuire	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
V.	NULL
E.	NULL
Curtiss	NULL
,	NULL
E.	NULL
L.	NULL
Larson	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Haseltine	NULL
.	NULL

1993	NULL
.	NULL

Influence	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
tax	NULL
and	NULL
rex	NULL
on	NULL
interleukin-2	NULL
gene	NULL
expression	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:1590	NULL
.	NULL

Los	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Schenk	NULL
,	NULL
K.	NULL
Hexel	NULL
,	NULL
P.	NULL
A.	NULL
Bacuerle	NULL
,	NULL
W.	NULL
Drige	NULL
,	NULL
and	NULL
K.	NULL
Schulze-Osthoff	NULL
.	NULL

1995	NULL
.	NULL

IL-2	NULL
gene	NULL
expression	NULL
and	NULL
NF-KB	NULL
activation	NULL
through	NULL
CD28	NULL
requires	NULL
reactive	NULL
oxygen	NULL
production	NULL
by	NULL
5-lipoxygenase	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:3731	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
P.	NULL
Ricber	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Bacuerle	NULL
.	NULL

1991	NULL
.	NULL

Reactive	NULL
oxygen	NULL
intermediates	NULL
as	NULL
apparently	NULL
widely	NULL
used	NULL
messengers	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
NF-KB	NULL
transcription	NULL
factor	NULL
and	NULL
HIV-1	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:2247	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
R.	NULL
Grassmann	NULL
,	NULL
B.	NULL
Fleckenstein	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Bacuerle	NULL
.	NULL

1992	NULL
.	NULL

Antioxidants	NULL
selectively	NULL
suppress	NULL
activation	NULL
of	NULL
NF-B	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
protein	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:6288	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

3055	NULL
Schenk	NULL
,	NULL
H.	NULL
,	NULL
M.	NULL
Klein	NULL
,	NULL
W.	NULL
Erdbriigger	NULL
,	NULL
W.	NULL
Drége	NULL
,	NULL
and	NULL
K.	NULL
Schulze-Osthoff	NULL
.	NULL

1994	NULL
.	NULL

Distinct	NULL
effects	NULL
of	NULL
thioredoxin	NULL
and	NULL
antioxidants	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
transcription	NULL
factors	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:1672	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

IKB	NULL
:	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
the	NULL
NF-KB	NULL
transcription	NULL
factor	NULL
.	NULL

Science	NULL
242:540	NULL
.	NULL

Hardin	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
D.	NULL
H.	NULL
Sherr	NULL
,	NULL
M.	NULL
DeMaria	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Lopez	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
simple	NULL
fluorescence	NULL
method	NULL
for	NULL
surface	NULL
antigen	NULL
phenotyping	NULL
of	NULL
lymphocytes	NULL
undergoing	NULL
DNA	NULL
fragmentation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
154:99	NULL
.	NULL

Rice	NULL
,	NULL
G.	NULL
C.	NULL
,	NULL
E.	NULL
A.	NULL
Bump	NULL
,	NULL
D.	NULL
C.	NULL
Shrieve	NULL
,	NULL
W.	NULL
Lee	NULL
,	NULL
and	NULL
M.	NULL
Kovacs	NULL
.	NULL

1986	NULL
.	NULL

Quantitative	NULL
analysis	NULL
of	NULL
cellular	NULL
glutathione	NULL
by	NULL
flow	NULL
cytometry	NULL
utilizing	NULL
monochloro-bimane	NULL
:	NULL
some	NULL
applications	NULL
to	NULL
radiation	NULL
and	NULL
drug	NULL
resistance	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

46:6105	NULL
.	NULL

Royall	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
H.	NULL
Ischiropoulos	NULL
.	NULL

1993	NULL
.	NULL

Evaluation	NULL
of	NULL
2',7'-dichlorofluorescein	NULL
and	NULL
dibydrorhodamine	NULL
123	NULL
as	NULL
fluorescent	NULL
probes	NULL
for	NULL
intracellular	NULL
H	NULL
,	NULL
O	NULL
,	NULL
in	NULL
cultured	NULL
endothelial	NULL
cells	NULL
.	NULL

Arch	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

302:348	NULL
.	NULL

Tagaya	NULL
,	NULL
Y.	NULL
,	NULL
Y.	NULL
Macda	NULL
,	NULL
A.	NULL
Mitsui	NULL
,	NULL
N.	NULL
Kondo	NULL
,	NULL
H.	NULL
Matsui	NULL
,	NULL
J.	NULL
Hamuro	NULL
,	NULL
J	NULL
.	NULL

Brown	NULL
,	NULL
K.	NULL
I.	NULL
Arai	NULL
,	NULL
T.	NULL
Yokota	NULL
,	NULL
H.	NULL
Wakasugi	NULL
,	NULL
and	NULL
J.	NULL
Yodoi	NULL
.	NULL

1989	NULL
.	NULL

ATL-derived	NULL
factor	NULL
(	NULL
ADF	NULL
)	NULL
,	NULL
an	NULL
IL-2	NULL
receptor/Tac	NULL
inducer	NULL
homologous	NULL
to	NULL
thioredoxin	NULL
:	NULL
possible	NULL
involvement	NULL
of	NULL
dithiol-reduction	NULL
in	NULL
the	NULL
IL-2	NULL
receptor	NULL
induction	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:757	NULL
.	NULL

Wakasugi	NULL
,	NULL
N.	NULL
,	NULL
Y.	NULL
Tagaya	NULL
,	NULL
H.	NULL
Wakasugi	NULL
,	NULL
A.	NULL
Mitsui	NULL
,	NULL
M.	NULL
Maeda	NULL
,	NULL
J.	NULL
Yodoi	NULL
,	NULL
and	NULL
T.	NULL
Tursz	NULL
.	NULL

1990	NULL
.	NULL

Adult	NULL
T-cell	NULL
leukemia-derived	NULL
factor/thioredoxin	NULL
,	NULL
produced	NULL
by	NULL
both	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type-I-	NULL
and	NULL
Epstein-Barr	NULL
virus-transformed	NULL
lymphocytes	NULL
,	NULL
acts	NULL
as	NULL
an	NULL
autocrine	NULL
growth	NULL
factor	NULL
and	NULL
synergizes	NULL
with	NULL
interleukin	NULL
1	NULL
and	NULL
interleukin	NULL
2	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:8282	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1990	NULL
.	NULL

Suppression	NULL
of	NULL
signals	NULL
required	NULL
for	NULL
activation	NULL
of	NULL
transcription	NULL
factor	NULL
NF-KB	NULL
in	NULL
cells	NULL
constitutively	NULL
expressing	NULL
HTLV-I	NULL
Tax	NULL
protein	NULL
.	NULL

New	NULL
Biol	NULL
.	NULL

2:894	NULL
.	NULL

Baichwal	NULL
,	NULL
V.	NULL
R.	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Bacuerle	NULL
.	NULL

1997	NULL
.	NULL

Apoptosis	NULL
:	NULL
activate	NULL
NF-KB	NULL
or	NULL
dic	NULL
?	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

7	NULL
:	NULL
R94	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1986	NULL
.	NULL

Inducibility	NULL
of	NULL
x	NULL
immunoglobulin	NULL
enhancer-binding	NULL
protein	NULL
NF-KB	NULL
by	NULL
a	NULL
posttranslational	NULL
mechanism	NULL
.	NULL

Cell	NULL
47:921	NULL
.	NULL

Grimm	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
K.	NULL
A.	NULL
Bauer	NULL
,	NULL
P.	NULL
A.	NULL
Bacuerle	NULL
,	NULL
and	NULL
K.	NULL
Schulze-Osthoff	NULL
.	NULL

1996	NULL
.	NULL

Bcl-2	NULL
down-regulates	NULL
the	NULL
activity	NULL
of	NULL
transcription	NULL
factor	NULL
NF-KB	NULL
is	NULL
induced	NULL
upon	NULL
apoptosis	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

134:13	NULL
.	NULL

Hockenbery	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Z	NULL
N.	NULL
Oltvai	NULL
,	NULL
X.	NULL
M.	NULL
Yin	NULL
,	NULL
C.	NULL
L.	NULL
Milliman	NULL
,	NULL
and	NULL
S.	NULL
J.	NULL
Korsmeyer	NULL
.	NULL

1993	NULL
.	NULL

Bcl-2	NULL
functions	NULL
in	NULL
an	NULL
antioxidant	NULL
pathway	NULL
to	NULL
prevent	NULL
apoptosis	NULL
.	NULL

Cell	NULL
75:241	NULL
.	NULL

Buttke	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Sandstrom	NULL
.	NULL

1994	NULL
.	NULL

Oxidative	NULL
stress	NULL
as	NULL
a	NULL
mediator	NULL
of	NULL
apoptosis	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
15:7	NULL
.	NULL

Hug	NULL
,	NULL
H.	NULL
,	NULL
S.	NULL
Strand	NULL
,	NULL
A.	NULL
Grambihler	NULL
,	NULL
J.	NULL
Galle	NULL
,	NULL
V.	NULL
Hack	NULL
,	NULL
W.	NULL
Stremmel	NULL
,	NULL
P.	NULL
H.	NULL
Krammer	NULL
,	NULL
and	NULL
P.	NULL
R.	NULL
Galle	NULL
.	NULL

1997	NULL
.	NULL

Reactive	NULL
oxygen	NULL
intermediates	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
CD95	NULL
ligand	NULL
mRNA	NULL
expression	NULL
by	NULL
cytostatic	NULL
drugs	NULL
in	NULL
hepatoma	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:28191	NULL
.	NULL

Bauer	NULL
,	NULL
M.	NULL
K.	NULL
A.	NULL
,	NULL
M.	NULL
Vogt	NULL
,	NULL
M.	NULL
Los	NULL
,	NULL
J.	NULL
Siegel	NULL
,	NULL
S.	NULL
Wesselborg	NULL
,	NULL
and	NULL
K.	NULL
Schulze-Osthoff	NULL
.	NULL

1997	NULL
.	NULL

Role	NULL
of	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
in	NULL
activation-induced	NULL
CD95	NULL
(	NULL
APO-1/Fas	NULL
)	NULL
ligand	NULL
expression	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:8048	NULL
.	NULL

Cui	NULL
,	NULL
H.	NULL
,	NULL
K.	NULL
Matsui	NULL
,	NULL
S.	NULL
Omura	NULL
,	NULL
S.	NULL
L.	NULL
Schauer	NULL
,	NULL
R.	NULL
A.	NULL
Matulka	NULL
,	NULL
G.	NULL
E.	NULL
Sonenshein	NULL
,	NULL
and	NULL
S.-T.	NULL
Ju	NULL
.	NULL

1997	NULL
.	NULL

Proteasome	NULL
regulation	NULL
of	NULL
activation-induced	NULL
cell	NULL
death	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:7515	NULL
.	NULL

Masutani	NULL
,	NULL
H.	NULL
,	NULL
K.	NULL
Hirota	NULL
,	NULL
T.	NULL
Sasada	NULL
,	NULL
Y.	NULL
Ueda-Taniguchi	NULL
,	NULL
Y.	NULL
Taniguchi	NULL
,	NULL
H.	NULL
Sono	NULL
,	NULL
and	NULL
J.	NULL
Yodoi	NULL
.	NULL

1996	NULL
.	NULL

Transactivation	NULL
of	NULL
an	NULL
inducible	NULL
anti-oxidative	NULL
stress	NULL
protein	NULL
,	NULL
human	NULL
thioredoxin	NULL
,	NULL
by	NULL
HTLV-I	NULL
Tax	NULL
.	NULL

Immunol	NULL
.	NULL

Lett	NULL
.	NULL

54:67	NULL
.	NULL

Nakamura	NULL
,	NULL
H.	NULL
,	NULL
K.	NULL
Nakamura	NULL
,	NULL
and	NULL
J.	NULL
Yodoi	NULL
.	NULL

1997	NULL
.	NULL

Redox	NULL
regulation	NULL
of	NULL
cellular	NULL
activation	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

15:351	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL

